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“Our bodies are as unknown to us as the ocean, 
both familiar and strange; the sea inside ourselves.” 
 
Philip Hoare 
  
SUMMARY 
Allergy related diseases have increased in the Western world, affecting nearly half of 
the children. Lifestyle, dietary and environmental changes are thought to be important 
for disease risk and disease development. The aim of the prospective ALADDIN 
(Assessment of Lifestyle and Allergic Disease During INfancy) cohort is to study how 
lifestyle and environmental factors during pregnancy and early childhood affect the 
development of allergic disease in children. 
 
The aim of this thesis was to study lifestyle, environmental and dietary exposures 
during pregnancy and infancy in relation to the development of allergic sensitization in 
the ALADDIN birth cohort. 
 
In study I we investigated if there are differences in concentrations of toxic and 
essential metals in maternal blood, placenta and cord blood between 40 mother-child 
pairs with and 40 without an anthroposophic lifestyle. Metal concentrations were 
analyzed using inductively coupled plasma mass spectrometry. We found higher 
concentrations of Cd, Pb and Co in samples from mother-child pairs with an 
anthroposophic lifestyle. None of the studied lifestyle factors explained the higher 
concentrations observed in this study. 
In study II we investigated if the long chain fatty acid composition in breast milk was 
associated with allergic sensitization in the child at two years of age. 225 mother-child 
pairs were included in this study. We found an inverse association between the 
concentration of omega-3 fatty acids and child sensitization at two years of age. 
However, this association could not explain the lower prevalence of sensitization 
among children of anthroposophic families. 
In study III we investigated if the incidence and prevalence of food, animal and pollen 
sensitization differed with lifestyle and age of the children. 100 children from 
anthroposophic, 209 from partly anthroposophic and 165 children from non-
anthroposophic families were included. We found a lower incidence of food allergen 
sensitization among children of anthroposophic families. The lower prevalence of 
sensitization in children from anthroposophic families was largely explained by the 
lower incidence of food sensitization before one year of age. 
In study IV we studied the development specific IgE to egg, milk and peanut from six 
months to five years of age in 372 children, with a particular interest in low levels of 
IgE. IgE concentrations were divided into non-sensitized (≤0.09 kU/L), low levels (0.1-
0.34 kU/L) and sensitized (≥0.35 kU/L). At six months, 5% of the children had low IgE 
levels to egg, 14% to milk and 4% to peanut. Low levels to egg seemed to be more 
transient than low levels to milk. Early low levels to egg and milk seemed to decrease 
over time, but might increase the probability of sensitization to inhalant allergens. 
 
In conclusion, this thesis together with previous publications from the ALADDIN 
cohort lead to better understanding of risk and protective factors during pregnancy and 
infancy for the development of allergic disease in children.  
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1 INTRODUCTION 
 
The focus, as well as the title of this thesis is lifestyle and environmental exposures in 
infancy in relation to allergic sensitization. The prevalence of allergic diseases has 
increased during the last decades, affecting nearly half of the children in Western 
countries1. The reason for disease development and the rapid increase in prevalence is 
still not entirely known. Genetic predisposition is an important risk factor but does not 
explain the rapid increase. Therefore, changes in lifestyle and exposure to 
environmental factors are thought to influence the risk for disease development2. 
 
The overall aim of the ALADDIN study is to increase our understanding of how the 
lifestyle of the parents and the child’s environment are associated with the development 
of allergic disease. 
 
I will limit the background to IgE sensitization and IgE mediated allergy. Regarding the 
exposures, I will only briefly discuss genetic and epigenetic factors behind allergy as 
none of my studies are in those fields of research. I go through how the known 
environmental risk and protective factors are believed to contribute to the development 
of the immune system in health and disease and, in some cases, preventive strategies to 
reduce the risk of allergic disease in childhood. 
 
 
 
 2 
2 BACKGROUND 
 
2.1 ALLERGY 
Allergy is an unwanted immunological reaction directed towards a non-harmful 
environmental substance called an allergen3,4. Allergens are usually small, stable 
proteins present in low amounts, but some carbohydrates have been identified to cause 
allergic symptoms as well3,5. Allergy can be atopic, which involves the production of 
allergen specific immunoglobulin E (IgE) antibodies, or it can be non-atopic where no 
antibodies are produced but where there is a cellular or a tissue/epithelial reaction3,4. 
 
Genetic factors are of great importance in the development of allergic disease6, where 
maternal atopy is believed to be a stronger risk factor for female offspring and vice 
versa7. Parental atopy has a dose response relationship to the risk of atopy in the 
offspring. Several studies also report gender related differences in allergy prevalence 
and that the female/male ratios may be age dependent8,9. Additionally, environmental 
exposures affect the transcription and translation of genes important for immune 
function10. 
 
 
 
2.1.1 Prevalence and clinical aspects 
During the past half century, the prevalence of allergic diseases have increased and, for 
asthma and rhinitis, reached a plateau in some countries1,11. Food allergy though still 
seems to be increasing in prevalence11-14. There are great variations in prevalence of 
allergy related diseases, with higher prevalence in Western countries1. In Sweden, the 
population based birth cohort BAMSE reported that 15% of the children were 
sensitized to an inhalant allergen at four years of age and that proportion increased to 
25% at eight years of age15. Food allergies affect nearly 8% of the children in Western 
countries11 and 6% in Europe13. At four years of age, 17% of the children in the 
BAMSE cohort were sensitized to a food allergen16 and food allergy in their early 
childhood (0-4 years) was reported for 6.8% of the children17.  
 
The clinical symptoms/atopic manifestations include food allergy, eczema, asthma and 
allergic rhinitis4. Food allergy is most prevalent in early childhood and commonly 
affects the oral mucosa, skin and the gastrointestinal tract18. Rapidly occurring 
symptoms include itching of mouth, gastrointestinal symptoms, urticaria, angioedema, 
airway symptoms and depending on the severity of the allergy, anaphylaxis. As many 
plant proteins causing allergies have structural similarities, pollen allergic individuals 
may experience cross reactivity to other similar allergens in food19. 
 
To understand who is at risk of developing allergic disease there is a need for 
diagnostic tools and parameters that can be followed over time. Skin prick-test, serum 
IgE and assessing asthma by spirometry are widely used in the clinic to diagnose and 
evaluate disease development18,20. These methods, accompanied by more experimental 
techniques, are also used in research settings. 
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2.1.2 Sensitization 
General references concerning sensitization development are Abbas et al. 201421 and 
Holgate et al. 201122. 
 
The immune system is divided into innate and adaptive immunity, and both play 
important roles in health maintenance and disease development. The innate immunity 
acts as a chemical and physical barrier to infectious agents. Important functions of the 
innate immune cells are antigen presentation and activation of the adaptive immune 
system. The adaptive immunity directs a specific response to the identified threat.  
 
All cellular responses involving the production of antibodies, including allergic 
sensitization, start similarly (Figure 1). Both endogenous and exogenous substances are 
constantly taken up by antigen presenting cells (APC) and presented to immune cells to 
identify potential threats. Allergens can enter through the skin, airway epithelia, 
digestive tract/intestinal epithelia and other mucous tissues. In the tissue the allergen is 
taken up by APCs, mainly by macrophages and dendritic cells (Figure 1, A). The APCs 
serve as a bridge between the innate and adaptive immune response. The APCs migrate 
to lymphoid tissue where they present the processed allergen to naïve T-cells on their 
major histocompatibility complex (MHC) II (Figure 1, B). The naïve T-cells, that 
through the T-cell selection have become specific for that particular antigen, recognize 
the antigen on their T-cell receptor (Fc-receptor) and can be activated. The activation of 
T-cells also requires cytokine signalling. Interleukin 4 (IL-4) is produced by the APC. 
 
The activated T-cell, now a Th-2 cell, can in turn activate antigen specific B-cells to 
mount a humoral response, i.e. the production of allergen specific IgE antibodies 
(Figure 1, C). Several different antibodies can be produced to an allergen. Although an 
allergen is a small protein or peptide, it provides several possible epitopes for antibody 
binding. It is not known what regulates the “choice” of epitope. Some individuals 
produce only one type of antibody to an allergen while others produce several different 
antibodies. In allergic individuals, knowledge of the specific antibodies produced by a 
patient is of importance in guiding the clinician to the correct therapy for the patient. 
 
In the first phase of sensitization, antibodies released to the surroundings are bound by 
Fc-receptors on mast cells and basophiles (Figure 1, D). Antibodies also cover the cell 
membranes of the B-cells. The activated B- and T-cells circulate in the body and 
eventually encounter the same allergen. 
This initiates the second step in the sensitization process. The allergen will bind to the 
IgE antibodies on the mast cells and cross-link the Fc-receptors (Figure 1, E). This will 
activate the degranulation of the mast cells releasing histamine and pro-inflammatory 
mediators in the surrounding tissue (Figure 1, F). 
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Figure 1 Schematic illustration of the cellular type I hypersensitivity reaction. In the 
upper half, the allergen is encountered for the first time and re-encountered in the 
lower half of the figure. Figure by Sara Fagerstedt Nilsson. 
 
Histamine causes vasodilation, itching and mucous secretion. In cases of severe allergic 
reactions, mast cell and basophil degranulation causes anaphylaxis, where airways can 
become obstructed by tissue swelling and smooth muscle contraction, and blood 
pressure can drop resulting in unconsciousness23. Untreated anaphylaxis is a life-
threatening condition. 
Activated B-cells can become antibody producing plasma cells. They can also form 
memory B-cells that last in the body for years.  
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2.1.2.1  Natural course of sensitization and the “atopic march” 
Production of IgE antibodies precedes allergic symptoms. The likelihood of allergic 
symptoms increases with increasing allergen specific IgE levels although no clear dose 
response relationship exists24,25. Several large cohort studies have gathered knowledge 
about the natural course of sensitization. On a population level, sensitization often 
begins with IgE to milk and/or egg in early infancy and later followed or replaced by 
IgE to indoor and outdoor inhalant allergens26,27. A subject of discussion throughout 
the years has been the “atopic march”. Accordingly, allergic disease commonly starts 
with IgE sensitization to common food allergens followed by atopic manifestations 
like eczema and later rhinitis and asthma27,28. This event chain is seen on a population 
level but it is unclear if the atopic march exists on an individual level. Should these 
manifestations be regarded as separate events or a causal chain of events? What is 
clear though is that having a sensitization or eczema are risk factors for food allergy, 
and that food allergy is associated with the development of rhinoconjunctivitis and 
asthma, so to some extent, an association exists29-32. Especially sensitization to hen’s 
egg in early infancy seems to predict later sensitization to aeroallergens33. 
 
Monosensitization to food allergens is rare. Analogous to the atopic march, the “food 
allergic march” describes the sensitization process to food allergens29. Commonly the 
age of onset of food allergy to egg, milk and peanut is during the first two years of 
life, followed by tree nuts, seeds, fish, seafood and fruits later in childhood and 
adolecense29,34.  
 
Some children outgrow their sensitization and allergy. For egg and milk, tolerance is 
usually achieved around school start35-37. Sensitization to peanut is of a more 
persistent character, although it has been demonstrated that also peanut allergy can be 
outgrown in around 20% of peanut allergic children38. 
 
 
2.1.3 Pre- and postnatal immune development 
During the prenatal period and for some time thereafter, the immune system is plastic 
and highly adaptive. Environmental exposure during this time-window may affect 
organ development10,30. Maternal and foetal immune systems are in close contact and 
maternal tolerance to paternal alloantigens is mediated through regulatory T-cells39. 
 
Development of the immune system starts early in foetal life. Early blood cell 
progenitors can be found in the circulation in gestational week 4 and the adaptive 
immune system occurs already between gestational week 15 and 2040. Membrane 
bound IgM is expressed on liver B-cells at week 10 and at week 12, B-cells can be 
found in the circulation40.  Maternal antibodies may cross the placenta and can be 
found in the foetal circulation. At birth, the IgM, IgA and IgE levels are low and most 
IgG is of maternal origin. Nevertheless, foetal IgG can be found in the spleen at 
gestational week 10 and IgE can be detected in foetal liver and lungs at week 1140. 
The neonatal immune cells are, however, rather immature and the immune response is 
limited40. Interestingly, the skin and gastrointestinal tract are more immunologically 
mature than the airway epithelia, perhaps explaining the earlier occurrence of atopic 
manifestations in these organs40. 
 
 6 
After birth and during the first years, the immune system develops towards an adult 
immune system with establishment of immune competence and formation of the 
immunological memory. As the immune system is highly dynamic, it continues to 
develop and adapt throughout life. 
 
 
2.2 ENVIRONMENT – RISK AND PROTECTION 
 
2.2.1 The hygiene hypothesis 
During the last century, the lifestyle in Westernized countries have gone through major 
changes including urbanization, decreased family size and decreased animal contact 
resulting in a change in microbial exposure compared to a rural environment. During 
this same period, the prevalence of asthma and allergic rhinitis increased too rapidly to 
be of an evolutionary origin. In year 1989, epidemiologist David Strachan stated that 
the risk of hay fever was related to family size where the risk of hay fever was reduced 
in children having older siblings as they would increase the exposure of the youngest 
child to both infectious and non-infectious microorganisms41. This “hygiene 
hypothesis” has since been revised to “the microbial hypothesis” as more knowledge 
through additional cohorts and epidemiological studies has been gathered42,43. 
 
 
2.2.2 Developmental origin of health and disease 
The development and function of a healthy immune system depends largely on 
interactions with the surrounding environment. Industrialization and urbanization have 
caused major changes in our environmental exposures and thus, a child born today is 
exposed to a vast array of chemical compounds that did not exist a hundred years ago. 
Developmental immunotoxicity (DIT) is a term used to describe the effect of various 
environmental toxicants on the vulnerable pre- and postnatal immune system 
development44. DIT is not only thought to influence development of allergic diseases. 
A diverse range of other disorders with low-grade chronic inflammation are also 
thought to have a developmental origin45. 
 
Harmful environmental exposures are thought to facilitate postnatal maintenance of the 
Th2 polarization seen during pregnancy, altering the pre- and postnatal maturation of 
innate immune cells and maintaining low grade inflammatory processes46. DIT is 
induced by exposure to biological materials, drugs, chemicals, medical devices, 
physical factors (like radiation) etc., extensively reviewed by Dietert and Zelikoff47. 
Toxicity testing for developmental effects have shown that extrapolation from adult 
data on dose sensitivity contains a large uncertainty44. In addition, toxic exposure in 
early life might cause more persistent adverse effects compared to adult exposure44. 
 
 
2.2.3 Exposure factors 
A complex interplay between the innate and adaptive immune system and 
environmental exposure shapes the maturation of the immune system. Several 
exposure factors have been, and are studied, in relation to allergic disease, often 
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closely related to the hygiene/microbial hypothesis and developmental 
immunotoxicity but also to genetic/epigenetic modifications (Figure 2). 
 
 
Figure 2 Exposure factors in the early life with possible associations to allergic 
disease development. Figure by Sara Fagerstedt Nilsson. 
 
 
2.2.3.1 Toxic compounds 
During the same time frame that the allergic diseases have increased in prevalence, the 
number of chemical compounds in our environment have dramatically increased 
(Information from Swedish Chemicals Agency, European Chemicals Agency and 
REACH).  Persistent organic pollutants have repeatedly been detected in maternal 
blood and cord blood from newborns48. In addition to toxic organic compounds, toxic 
metals are also found in the placenta and cord blood. Some metals, like cadmium, 
accumulates in the placenta which might affect the transport of essential micronutrients 
to the foetus 49. Cadmium might also alter hormonal regulation and cortisol by 
suppressing the transcription of the cortisol converting enzyme 11β-hydroxysteroid 
dehydrogenase type 2 in placenta syncytiotrophoblast cells50. Other metals, like lead 
and arsenic, pass through the placenta51. Lead exposure has been shown to shift the 
immune balance to Th2 dependent responses52. In experimental animal models, lead 
has been shown to induce adverse immunotoxic effects in the offspring depending on 
the gestational age at exposure53. 
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Prenatal arsenic exposure may induce oxidative stress and inflammatory processes in 
the placenta54. Arsenic also seems to reduce the number of placental T-cells and alter 
cord blood cytokines54. Pre- and early postnatal arsenic exposure has been shown to 
induce oxidative stress and inflammation, causing damage in the developing lung 
tissue55. Arsenic exposure has in cohort settings been associated with a reduced lung 
function with gender related differences55. 
 
Outdoor air pollution, as exposure to traffic related air pollution, particulate matter, 
ozone, nitrogen dioxide and sulphur dioxide have been associated with asthma in 
children and adults56. The effects are thought to be mediated through increased 
oxidative stress in the airway epithelium. 
 
Smoking during pregnancy has in several studies showed a clear association to wheeze 
and asthma57,58. Adding important information to this risk factor is a study where the 
methylation effects of in utero exposure to smoking was dependent on smoking at a 
certain stage of pregnancy59. This knowledge reinforces/emphasise the importance of 
toxicity testing during different stages of gestation. 
 
 
2.2.3.2 Microbial exposure 
The maturing immune system learns to distinguish between self and non-self, as well 
as harmful and innocuous molecules and compounds. As all surfaces of the human 
body that are in contact with the external world are inhabited by microbes, the 
“diplomatic” relations to these inhabitants are extremely important for the wellbeing of 
the host60. The microbiome shows geographical differences and comparing the maps of 
allergy prevalence worldwide and microbiome in different countries, one can easily 
understand why microbiota is of such interest to allergy researchers1,61. It has become 
increasingly clear during the last years that the microbial exposures ought to take 
place during a certain developmental phase or time window, although the timing is 
currently unknown60. It is thought that that the microbial diversity is more important 
than exposure to some certain bacterial strains or viruses62,63. 
 
It was previously believed that the intrauterine milieu was sterile, but recent research 
has showed that the microbial exposure may begin already in utero64. More 
established knowledge though, is the importance of a vaginal delivery and the transfer 
of maternal microbial flora to the newborn65,66.  
Studies have demonstrated differences in gut microbiota comparing healthy and 
allergic children67,68. In a study by Kalliomäki et al, the differences were observed prior 
to the occurrence of symptoms67. The results of prospective studies indicate that the 
time window for healthy gut colonization is in the early life69-71. This early 
programming of the immune system by exposure to microbes, perhaps occurring 
already in utero, may be important for tolerance development in infancy62. 
 
The rural farm environment has been shown to hold allergy protective features, and 
has thus been studied extensively72,73. A comprehensive review by von Mutius and 
Vercelli contain a table on studies investigating the effect of childhood farm exposure 
on allergic disease73. These studies have shown that contact with livestock, animal 
feed and consumption of unprocessed farm milk reduce the risk of allergic disease in 
childhood73,74. Interestingly, the farm effect was independent of several other 
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traditional risk factors as day care, family size, breastfeeding and heredity of 
allergies. Both pre- and postnatal farm environment exposure seems to have allergy 
protective effects. Maternal exposure to barn/stable environment and consumption of 
unprocessed cow’s milk during pregnancy has been shown to induce 
immunomodulatory, allergy protective effects75-77. Child consumption of unprocessed 
cow’s milk has also been shown to be allergy protective78,79. It was previously 
demonstrated in the ALADDIN study that living on a farm and parental sensitization 
modulate the gene expression in the placenta80. 
 
 
 
Figure by Sara Fagerstedt Nilsson. 
 
 
Mechanistic evidence for farm related allergy protection are scarce, but in a recent 
article Schuijs et al. demonstrated in mice how continuous low dose bacterial 
endotoxin exposure inhibited dendritic cell activation and therefore supressed Th2 
immunity81. The group found that a variant of a gene encoding an enzyme in the lung 
epithelia mediated this effect. They investigated blood samples from the GABRIELA 
study and found that the farm children also had the genetic variant that mediated the 
protective effect81. 
 
Effects mediated by exposure to bacterial endotoxin was also thought to explain the 
differences in atopy seen between Amish and Hutterite children82. Both Amish and 
Hutterite people originate from European farmers that during the Protestant 
Reformation migrated to the United States, where they have lived isolated and 
strongly preserved their traditions. Both groups have similar genetic background and 
lifestyle but the prevalence of sensitization and asthma was significantly lower in the 
Amish children. A difference was found in the dust samples where those from the 
Amish homes contained almost seven times the amount of endotoxin found in the 
Hutterite homes82. 
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Antibiotics negatively effects gut microbiota and has thus been suggested to have a 
role in allergy development. Prenatal maternal antibiotics may be associated with an 
increased risk of asthma and wheeze in the child83. Several prospective studies have 
found associations between antibiotics and antipyretics and asthma/wheezing, but it 
cannot be excluded that it is due to reverse causation84-86. Children with respiratory 
symptoms have an increased risk of having prescription antibiotics/antipyretics. 
Antibiotic use in infancy shows no association with eczema or sensitization84. 
 
 
2.2.3.3 Pathogenic viral exposure 
The immune system continues to learn, develop and adapt to the environment. Early 
contact with pathogens strongly shapes the developing immune system. Viral 
respiratory infections have been extensively studied as risk factors for asthma87. 
Bronchiolitis in the first year of life has been associated with increased asthma risk88. 
Respiratory syncytial virus and human rhinovirus are the most common viruses to 
cause bronchiolitis in infants89. Additionally, rhinovirus infection was demonstrated 
to be associated with an increased sensitization to aeroallergens90. 
 
Although several studies have shown positive or negative associations between 
certain microbial and viral exposure, it is currently not known what type of infections 
are important in programming health and disease and if there are specific time 
windows for that exposure87. 
 
 
2.2.3.4 Exposure to allergens 
Not only microbes influence the developing immune system. Potential allergenic 
compounds are inhaled, ingested and taken up through skin or mucosal tissue. 
Exposure through the skin rather than oral exposure has been shown to increase the risk 
of food allergy and sensitization91. 
 
Maternal avoidance diets have failed to limit the increase of food allergy and a repeated 
Cochrane review concluded that avoidance diet in high-risk women during pregnancy 
was unlikely to reduce the risk of atopic disease in the child92. Recent randomized trials 
are indeed suggesting the opposite93. Increased food diversity in the first year of life 
have been inversely associated with asthma, food allergy and food sensitization94. 
Delayed introduction of cow’s milk and other foods was shown to be associated with 
an increased risk of atopic manifestations in the first two years of life in the KOALA 
study95. Additionally, a Finnish study showed that reduced food diversity during the 
first year of life was associated with a higher risk of allergy and asthma in childhood96. 
Early introduction of allergenic foods in the diet has been a success in the case of 
peanut and the LEAP study on high risk children97 but also raising doubts as results 
were less convincing for other foods than peanut in a non-selected population98. 
However, the study reported a lower prevalence of egg and peanut allergy in the per-
protocol group98. Notable is that the National Institute of Allergy and Infectious 
Diseases (NIAID) in the US have changed the guidelines regarding peanut based on a 
single trial (LEAP study). 
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Although not the focus of this thesis, it should be added that indoor and outdoor 
allergen exposure is also of importance. Modern homes are far different from the 
dwellings of our ancestors. Additionally, a significant proportion of the time is spent 
indoors and therefore the immune system is exposed to indoor inhalant allergens from 
house dust mites, cockroaches and pets99. The timing, duration and amount of 
exposure seems to be of importance99,100. Interestingly there seem to be a dose 
dependent association in the exposure to allergens demonstrated in Figure 3101-104. 
 
 
 
Figure 3 A non-linear dose dependent relationship between prevalence of 
sensitization and exposure level to allergens. 
 
 
 
2.2.3.5 Breast feeding and breast milk 
Exclusive breastfeeding for the first six months of life and continued complementary 
breastfeeding thereafter has been recommended by the World Health Organization, 
since breastfeeding reduces morbidity and mortality in infancy especially where clean 
drinking water is a scarce commodity. Breastfeeding for at least six months has been a 
standard guideline in many countries including Sweden. 
 
Human milk contains important nutritional and bioactive compounds105. The milk that 
is produced during the first few days post partum is the colostrum. It contains secretory 
IgA, leukocytes, lactoferrin, developmental factors like growth factors and higher 
levels of sodium, chloride and magnesium than mature milk105. After a few weeks post 
partum, the milk is considered fully mature105. The mature milk contains approximately 
0.9-1.2 g protein, 3.2-3.6 g fat and 6.7-7.8 g lactose per 100 ml105. The mature milk also 
contains a variety of immunomodulatory factors thought to influence the development 
of oral tolerance to food106. 
 
It was previously demonstrated in the ALADDIN cohort that the phenotype of breast 
milk exosomes varied with lifestyle and maternal sensitization107. Exosomes are small 
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membrane vesicles budding from the endosomal compartment of various cells and used 
in cell-to-cell communication108. 
 
 
2.2.3.6 Fatty acids in breast milk 
The fatty acid (FA) profile in breast milk varies in relation to maternal diet. In many 
parts of the world, the ratio of omega-3 to omega-6 long chain polyunsaturated fatty 
acids (LC-PUFA) has shifted towards omega-6 FAs due to the decreasing levels of 
omega-3 FAs in the diet109. This is the basis of the lipid hypothesis by Hodge et al.110 
and further developed by Black and Sharpe109 stating that the low intake of omega-3 
PUFA could shift the inflammatory balance towards a pro-inflammatory state, leading 
to allergic disease. Both omega-3 and omega-6 (Figure 4) are precursor molecules for 
inflammatory mediators and therefore their availability could regulate the inflammatory 
status. 
 
 
Figure 4 Example of an omega-3 FA (linolenic acid) and an omega-6 FA (linoleic acid). 
 
 
The association between breastfeeding and allergic disease has been evaluated in 
several studies with somewhat contradictory conclusions. Prolonged breastfeeding has 
been associated with an increased risk of atopic eczema111,112. On the other hand, it has 
also been demonstrated that exclusive breastfeeding for at least three months reduced 
the risk of atopic dermatitis in high-risk infants113. The same study saw no such 
association in children without atopic parents. The association between breastfeeding 
and asthma has been evaluated in several meta-analyses concluding that breastfeeding 
protects from childhood asthma114. The study that reported an increased risk of eczema 
also reported that breastfeeding reduced the risk of wheezy disorders in high-risk 
infants112. This Danish study saw no associations between FA composition and their 
outcomes. 
 
The FA composition in breast milk in relation to allergic disease has been evaluated in 
several large studies115-119. Two recent Cochrane reviews concluded that neither pre- 
and postnatal supplementation120 nor supplementation in infancy121 of omega-3 PUFA  
reduced allergy, asthma, eczema or food allergy in children and that the quality of 
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evidence was low121. Studies on high-risk infants support their findings and report that 
higher omega-3 in colostrum was associated with increased risk of allergic 
disease122,123.  On the contrary, a report recently published by Bisgaard et al, (the 
COPSAC cohort) from a randomized trial on omega-3 supplementation found that 
omega-3 supplementation in the third trimester reduced the risk of persistent wheeze or 
asthma and lower respiratory tract infections124. The allergy protective effect of omega-
3 and/or fatty fish consumption is supported by several Nordic studies125-128. 
Interestingly, a recent publication from the PASTURE study reported that the higher 
omega-3 content might contribute to the allergy protective effect of unprocessed cow’s 
milk (farm milk)129. 
 
In addition to omega-3 PUFAs, the breast milk also contains other molecules with 
suggested immunomodulatory effects. A study on mice found that breast milk soluble 
IgA had long lasting positive effects on the gut microbiome130. Also in humans, where 
the breast milk previously was considered sterile, research has now revealed that both 
colostrum and mature milk contain numerous bacterial species with possible probiotic 
features (for a list, see Table 1 in Fernández et al)131. Apart from the breast milk 
bacterial contribution to a healthy microbiota in the infant gut, the bacteria have been 
shown to reduce infections and influence the maturation of the immune system131. 
Although not entirely clear, the origins of the breast milk bacteria are thought to be the 
infant oral microflora, the breast skin microbiota and the maternal gut microflora131. In 
addition to IgE and bacteria, breast milk also contains a large variety of non-digestible 
prebiotic oligosaccharides. The oligosaccharides promote a healthy microbial 
environment by “cleaning” the gut from pathogenic bacteria and also promote 
colonization of bifidobacteria and lactobacilli60. 
 
 
2.2.3.7 Dietary exposure 
Diet is one of the most important environmental exposure factors. As mentioned 
earlier, maternal food allergen avoidance diets have proven inefficient in preventing 
atopy and instead, earlier introduction of foods is suggested to induce 
tolerance92,132,133. Maternal diet before and during pregnancy is thought to influence 
the health and disease risk in the offspring through epigenetic mechanisms134. 
Probiotic bacteria, prebiotic oligosaccharides, PUFAs, antioxidants and vitamin D 
have all been suggested to influence immune development and function132.  Dietary 
changes in the Western world have led to a decreased intake of fatty fish, seeds, nuts, 
fibres, fruits and vegetables containing much of the aforementioned components132. 
 
Fruits and vegetables are important sources of antioxidants like vitamin E and C, 
selenium, zinc and β-carotene132. There is some evidence of associations between 
lower intake of antioxidant rich foods and allergic disease but at the moment, 
recommendations of a balanced diet has better evidence than supplementation with 
specific vitamins or minerals132. 
 
The National Food Agency in Sweden recommends eating fish 2-3 times per week 
although it is important, especially for pregnant women and children, to avoid fish 
and seafood from certain “polluted” waters. Fish is also a good source of vitamin D. 
In addition to the role of vitamin D in calcium absorption and maintaining bone 
health, vitamin D has important functions in the immune system135. Several studies 
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have investigated the association between serum vitamin D levels and allergic 
disease135. Low serum levels have repeatedly been measured in atopic individuals135. 
Many studies have reported inadequate levels in relation to national 
recommendations, especially in wintertime in certain geographical regions when 
sunlight is scarce. Interestingly, a Finnish study reported a non-linear relationship 
between IgE sensitization and vitamin D136. Studies on asthma and vitamin D show 
inconclusive results137,138. More studies are needed to strengthen the evidence if 
vitamin D has a role in allergic disease135. Perhaps prospective studies starting with 
maternal vitamin D status during pregnancy could shed more light on this issue. 
 
Food can also be an exposure source for environmental toxicants such as pesticides 
and persistent organic pollutants139. In our cohort study, many of the anthroposophic 
and partly anthroposophic families choose organically or biodynamically produced 
food. Organically produced food contains significantly lower levels of pesticides 
compared to conventionally produced food140,141. Consumers of organic food also 
have less pesticide metabolites in their urine142. The association between consumption 
of organic food and atopic disease has been investigated in the KOALA birth 
cohort143. Kummeling et al. reported that consumption of organic dairy products was 
associated with a lower eczema risk in children up to 2 years. No associations were 
found for total organic diet or other specific organic foods. 
 
The role of microbiota for maintaining a healthy immune system has been investigated 
in several studies, both in observational studies and in trials132. Probiotics have been 
suggested as primary prevention strategy for allergic disease but currently there is not 
enough evidence proving such therapy to be effective and have lasting effects132. 
Fermented vegetables contain live bacteria and/or yeast144. The process of fermentation 
occurs naturally by microorganisms in the food or by adding bacteria/yeast culture144. 
The microorganisms use sugars in the food for energy, producing other compounds like 
lactic acid instead144. Possible health benefits from consumption of fermented foods 
have been studied with the most positive outcomes from the consumption of fermented 
dairy products144. 
 
 
  
2.3 ANTHROPOSOPHY 
Anthroposophy is a holistic view of life that was founded in the early 20th century by 
Rudolf Steiner. Most aspects of life are encompassed by anthroposophy including 
medicine, healthcare, childbirth, parenting, education, art, architecture, agricultural 
methods and food. The general idea behind anthroposophic medicine can be described 
by the Latin proverb “medicus curat, natura sanat”, translated as “the physician cares 
for the patient but nature heals”. The anthroposophic medicine therefore has a 
restrictive use of “modern” medicine such as antibiotics, antipyretics and vaccinations, 
instead using homeopathic/nature medicine145. The aim is to treat the cause and the 
patient holistically, not only the symptom (e.g. fever). Integrated in the anthroposophic 
medicine is also the therapy through art including painting, music and eurythmy. 
 
Vaccinations are sometimes refused by parents who believe that infectious diseases are 
beneficial for the development of the immune system 146. Especially the measles, 
mumps and rubella (MMR) vaccine is avoided with the explanation that these diseases 
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are less serious than those in the diphtheria-tetanus-pertussis (DTP) vaccination146. 
However, studies demonstrate that there is no evidence of protective effects from MMR 
diseases on atopy, or that vaccinations would cause atopic diseases146,147. There are 
even studies showing that MMR vaccination may have a protective effect against 
allergy and asthma in childhood148.   
 
Biodynamic or organic farming/cultivation are the preferred agricultural methods. A 
peculiar characteristic of dietary preferences is the use of fermentation to preserve 
vegetables. Fermented vegetables are also consumed by the children. 
 
The Swedish anthroposophic community has its centre in Järna, south of Stockholm. 
Sweden’s only anthroposophic hospital, Vidarkliniken, is also located in Järna. 
 
 
 
Figure by Sara Fagerstedt Nilsson 
 
 
2.3.1 The ALADDIN cohort 
The hygiene hypothesis inspired the search for allergy protective factors within the 
anthroposophic population. It started with a cross-sectional study comparing children 
from Steiner schools with children from public schools in the same area regarding 
allergy outcomes (asthma, allergic rhinoconjunctivitis, atopic dermatitis, food allergy, 
allergic urticaria, skin prick-test and IgE sensitization)149. The study revealed that the 
anthroposophic lifestyle was associated with a lower prevalence of both clinical 
symptoms of allergy, allergic sensitization and positive skin prick-test149. However, the 
study design could not point out any specific lifestyle exposure factors responsible for 
the observed differences. 
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A larger cross-sectional European study, PARSIFAL, was conducted to find what 
aspects of the anthroposophic lifestyle contributed to the observed allergy protection. In 
this study of 4606 Steiner school children and 2024 reference children, the authors 
could confirm the results of the previous study by Alm et al. 1999 adding that the 
restrictive use of antibiotics and antipyretics was associated with the reduced risk of 
allergic disease in the children150.  
 
Later, in 2006, results from the PARSIFAL study concluded that the most pronounced 
allergy protection was associated with growing up on a farm. The lower prevalence of 
allergic disease and sensitization in the anthroposophic population was less clear in this 
study and there were geographical variations151. 
 
With the results from the cross-sectional studies in mind, the prospective birth cohort 
Assessment of Lifestyle and Allergic Disease During INfancy (ALADDIN) study was 
founded in 2004 recruiting 330 pregnant women in their third trimester and later 
additionally 222 families who were included at two months post partum. The cohort is 
described in detail in the materials and methods section. 
 
 
2.3.1.1 Previous results of the ALADDIN study 
The anthroposophic lifestyle aims to reduce negative stress for the infant. This could be 
confirmed in the ALADDIN cohort where the infants from anthroposophic families had 
significantly lower levels of salivary cortisol152. The parents had similar levels across 
lifestyle groups, indicating that the lifestyle related stress reduction is more relevant for 
the children. Additionally, Stenius et al, showed that salivary cortisol was positively 
associated with allergic sensitization and allergic symptoms at two years of life, 
although there was no lifestyle related effect on this association153. Altered regulation 
of the hypothalamus-pituitary-adrenal (HPA) axis could influence the development of 
allergic disease154-156. Altered levels of stress hormone is expected in many diseases and 
it is possible that the association between stress and allergic disease is bi-directional157. 
 
The findings of the two cross-sectional studies149,150 were confirmed also in prospective 
cohort settings, establishing that the anthroposophic lifestyle is associated with a 
reduced risk of allergic sensitization in infancy158. Additionally, Marell Hesla et al. 
showed that the anthroposophic and partly anthroposophic lifestyles were associated 
with a reduced risk of parent reported food hypersensitivity and recurrent wheeze up to 
two years of age159. Interestingly, this study found that delayed body wash of the 
newborn was associated with a reduced risk of sensitization159, possibly associated with 
the differences seen in vernix proteins in children with atopic eczema and differences in 
lipid composition related to lifestyle differences160,161. 
 
Several characteristics of the anthroposophic lifestyle, like homebirth, stress reducing 
environment, restrictive use of antibiotics, prolonged breast feeding and consumption 
of fermented vegetables may influence the gut microbiota. Gut microbiota was 
analysed in stool samples from 128 mother-child pairs (child samples at 6 days, 3 
weeks, 2 and 6 months post partum). Marell Hesla et al. found that caesarean section 
and breastfeeding, but not lifestyle, had a significant impact on gut microbiota162. 
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3 PROBLEM FORMULATION 
During the last decades, there has been a notable increase in prevalence of immune 
related diseases. That increase cannot only be due to genetic adaptation/evolution. 
Therefore, answers are sought in changes in our way of life during the same time-
period. Urbanization, intensive agriculture and the vast number of chemical compounds 
in our daily life and environment have caused major changes in what we are exposed 
to. Of particular concern is harmful exposure during the sensitive prenatal period that 
may have unfavourable developmental effects. Priming of the immune system towards 
an inflammatory phenotype starts early in life. Therefore, we are investigating if and 
how exposures during pregnancy and infancy can affect development of allergic 
sensitization. Regarding this thesis, the following research questions have been raised. 
 
I. Immunomodulatory effects of several toxic metals have been studied both 
in vivo and in vitro. Metals are taken up by plants and animals and thus food 
is a major source of exposure. Children from families with an 
anthroposophic lifestyle have a lower risk for sensitization. Our hypothesis 
was that the anthroposophic population have a lower level of exposure to 
immunomodulatory environmental pollutants, e.g. toxic metals, and that this 
could partly explain the sensitization differences. 
 
II. Changes in both eating habits and dietary preferences over the last decades 
have resulted in a shift in omega-3 to omega-6 ratio. According to the lipid 
hypothesis this might be one possible contribution to the increase in 
immune related diseases as allergy and asthma. Therefore, we wanted to 
investigate if the lower prevalence of allergic sensitization seen in children 
in families with an anthroposophic lifestyle could be explained by fatty acid 
composition in breast milk. 
 
III. Sensitization to food allergens is still increasing and is the most prevalent 
form of allergy in young children. In addition, according to the atopic march 
and seen on a population level, sensitization to food allergens may be 
followed by sensitization to other allergens and/or developed into allergic 
disease later in life. The cause for this developmental pattern is not known 
and few studies have prospective sampling from infancy. Therefore, we 
wanted to study if the association between lifestyle and sensitization to 
food, animal and pollen allergens is dependent on the age of the child. 
 
IV. In Study III we found that an anthroposophic lifestyle is associated with a 
lower incidence of food sensitization in infancy and we wanted to 
investigate early food sensitization further to increase our knowledge in the 
area. In study IV we followed the development of specific IgE to egg, milk 
and peanut from six months until five years. Our focus was on low levels 
(0.1-0.34 kU/L) of specific IgE as concentrations below 0.35 kU/L are less 
investigated and not well understood. 
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4 AIMS 
 
The aim of this thesis was to study the associations between lifestyle, environmental 
and dietary exposures during pregnancy and infancy and development of allergic 
sensitization in the ALADDIN study. 
 
The specific aims of this thesis were: 
 
I. To elucidate if mothers with an anthroposophic lifestyle have a lower 
exposure to potentially immunomodulatory toxic metals (i.e. foetal 
exposure to toxic metals and essential metals), Article I. 
 
II. To measure the long chain fatty acid composition in breast milk samples 
and to assess relationship between fatty acid concentrations (particularly 
omega-3, omega-6 and ruminant fatty acids) and child sensitization up to 24 
months of age, Article II. 
 
III. To investigate if sensitization to food, animal and/or pollen allergens 
differed with the child’s age and parental lifestyle, Article III. 
 
IV. To follow different levels of specific IgE concentrations to egg, milk and 
peanut from six months to five years, Article IV (in manuscript). 
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5 MATERIAL AND METHODS 
 
5.1 THE ALADDIN COHORT 
All four studies are based on the prospective birth cohort study ALADDIN. 
 
5.2 STUDY DESIGN 
Between September 2004 and March 2011, a total of 552 families were recruited from 
anthroposophic Maternal-Child Health Care Centres (MCHCC’s) (n=312) in Järna 
(Vidarkliniken and Kirstens Familjehälsa) and Stockholm (Vidarkliniken at Hälsans 
Hus and Rosenlund hospital) and from conventional MCHCC’s (n=240) in Järna (Järna 
Vårdcentral) and Södertälje (Oxbackskliniken). In the second trimester, their midwife 
asked the parents if they wanted information about the ALADDIN study. 
 
The initial 330 families (ALADDIN Original) were enrolled in the study at gestational 
week 28-32. Inclusion criteria were no severe illness before or during pregnancy and 
child born ≥ gestational week 35. Additionally 222 families (ALADDIN Plus) were 
included at two months post partum. An overview of the data and sample collection 
from the participants is provided in Figure 5. 
 
 
 
Figure 5 Flow chart of the samples and questionnaire data used for studies included in 
this thesis. Roman numbers denote article numbers. 
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5.2.1 Lifestyle 
To evaluate the degree of anthroposophy of the participants in the ALADDIN cohort, 
the families were divided into three lifestyle groups based on following questions in the 
questionnaire. 
 
1.” What kind of preschool/school will your child probably go to?”  
 a) Public preschool/school. 
 b) Waldorf/Steiner preschool/school. 
 c) Other private school. 
 
2. “Do any of the parents, no matter what preschool/school you have planned for your 
child, have an anthroposophic view of life? (Yes/No) 
 
3. “Is the family’s daily life influenced by an anthroposophic view of life?” (Yes/No) 
 
If the parents answered they will choose an anthroposophic (Steiner or Waldorf 
school), and “yes” on the following two questions and attended an anthroposophic M-
CHC, the family was regarded as having an anthroposophic lifestyle. If they answered 
that they will choose a public school or private other than anthroposophic and “no” on 
the following questions and went to a conventional M-CHC, the family was regarded as 
not having an anthroposophic view of life. All other combinations were regarded as 
partly anthroposophic. 
 
 
5.2.2 Study populations 
All studies in my thesis are based on the ALADDIN study. Depending on specific 
aims, inclusion criteria and sample availability, different populations have been chosen 
for the individual studies. 
 
 
5.2.2.1 Article I 
Mothers eligible for randomization for study I were mothers with and without an 
anthroposophic lifestyle with available placenta samples. Placentas were collected at 
270 of the 328 deliveries (Figure 6). Exclusion criteria for study I were maternal 
smoking before or during pregnancy and/or paternal or other person smoking indoors 
during pregnancy. Available number of placentas for study I were 52 placentas from 
mothers with and 66 placentas from mothers without an anthroposophic lifestyle. We 
randomly selected 40 placentas from each lifestyle group.  
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Figure 6 The selection process of the 40 anthroposophic and 40 non-anthroposophic 
mother-child pairs for study I.  (ICPMS = inductively coupled plasma mass 
spectrometry). 
 
 
5.2.2.2 Article II 
Inclusion criteria for study II were having a lifestyle categorization, providing a breast 
milk sample at two months post-partum and at least one blood sample from the child at 
any of the time-points (6, 12 or 24 months). In total, 225 mother-child pairs provided 
both breast milk and blood samples. 
 
 
5.2.2.3 Article III 
Inclusion criteria for study III were having a lifestyle categorization and at least one 
blood sample taken at any of the time-points; 6, 12, 24 or 60 months. At time of study 
III, a number of children had not yet completed the five-year follow-up. Of the eligible 
552 children, 100 from anthroposophic, 209 from partly anthroposophic and 165 from 
non-anthroposophic families were included in study III. The inclusion process and 
number of available blood samples for study III are presented in the flowchart in Figure 
7. 
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Figure 7 Flowchart of the inclusion process and available blood samples at each time-
point for the three lifestyle groups. 
* Not all children had completed the five year follow-up at the time of this study. 
 
 
5.2.2.4 Article IV 
Inclusion criteria for study IV were having an analysed blood sample at six months and 
providing at least one additional blood sample at a later time-point to enable 
longitudinal analysis. 
 
 
5.3 SAMPLES USED IN THIS THESIS 
Article I evaluates trace elements in maternal blood, placenta and cord blood. I did all 
sample preparations from the samples stored in our biobank. The metal analysis was 
carried out at Marie Vahter’s laboratory; metals and health, Institute of Environmental 
Medicine, Karolinska Institutet. 
 
Article II relates fatty acids in breast milk to sensitization up to two years of age. 
Lonneke Janssen Duijghuijsen and Axel Mie did the lipid extraction from breast milk 
and the fatty acid analysis was done at Swedish University of Agricultural Sciences 
(SLU). 
 
Blood IgE analyses used in Articles II, III and IV were continuously done by 
laboratory technicians at the clinical immunology laboratory at Karolinska University 
Hospital and at Forskningscentrum Södersjukhuset. 
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5.3.1 Placenta samples 
Placenta sample collection is described in detail in article I. Briefly, placenta samples 
were collected by midwives after delivery. A cross-sectional sample was cut out, 
washed, frozen in liquid nitrogen and stored at -80°C 163. In contrast to the procedures 
for sample collecting for trace element analysis, where the risk of external metal 
contamination is minimized (e.g. using acid washed titanium knives), the ALADDIN 
samples were cut with a scalpel. To compare sample collecting methods we conducted 
a pilot study with three samples using each method. No significant differences in metal 
concentrations between the two methods were found. 
 
 
5.3.2 Blood samples 
Blood samples from the parents were collected at inclusion during the third trimester or 
during the neonatal period. At delivery, midwives collected umbilical cord blood by 
aspiration, and blood from the children were collected at 6, 12, 24 and 60 months of 
age. All blood samples were non-fasting. Blood samples were collected in sodium 
heparin tubes. The blood samples were separated using Ficoll-Paque (General Electric 
Healthcare Bio-Sciences, Uppsala, Sweden) into plasma and blood cells and stored at -
20°C. Ficoll-Paque was compared with direct centrifugation to investigate if Ficoll-
Paque separation could influence trace element concentrations. Ficoll-Paque did not 
influence elements analysed in article I 164. 
 
 
5.3.3 Breast milk sample collection and lipid analysis 
Breast milk samples were collected at two months post partum by the participants and 
kept at +4°C. The milk samples were frozen within 24 h from collection and stored at -
80°C. The lipids have to be extracted from the milk sample for analysis of the FAs. 
Lipids were extracted in hexane using a procedure described by Hara and Radin165. 
Lipids are as such not suitable for gas chromatography and therefore they have to be 
transformed to fatty acid methyl esters (FAMEs). The lipids were saponificated using 
sodium hydroxide and derivatised to FAMEs using methanol and the esterification 
reaction was catalysed using boron trifluoride. The esterification procedure was 
described by Appelqvist166. The FAMEs were analysed with gas chromatography with 
a flame ionisation detector (GC-FID). The FAMEs are vaporised at injection in the gas 
chromatograph column where the FAMEs are separated. The time it takes for the 
FAMEs to pass through the column depends on their boiling point and their interactions 
with the stationary phase in the column. For detection, the FAMEs are burned in a 
hydrogen flame and thereafter the electric current generated by the resulting ions is 
measured. The method is described in detail by Fredriksson Eriksson and Pickova167. 
 
 
5.3.4 Trace element analysis 
The procedure for trace element analysis is described in detail in article I. Briefly, 
maternal and cord blood was alkali diluted and placenta tissue samples were acid 
digested before trace element analysis. Toxic elements cadmium (Cd), arsenic (As) and 
lead (Pb) and essential elements calcium (Ca), cobalt (Co), copper (Cu), iron (Fe), 
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magnesium (Mg), manganese (Mn), molybdenum (Mo), selenium (Se) and zinc (Zn) 
were quantified in placenta and blood samples using inductively coupled plasma mass 
spectrometry (Agilent Technologies, Tokyo, Japan). 
 
 
5.3.5 Sensitization 
IgE concentrations were analysed in blood plasma from the parents, cord blood and 
blood from the children. Parental sensitization was determined using Phadiatop 
(Thermo Fisher Scientific, Uppsala, Sweden) for 11 common inhalant allergens. If the 
Phadiatop was ≥0.35 kU/L, s-IgE to 9 allergens were analysed in the sample (birch, 
timothy, mugwort, mould, two species of house dust mite, cat, dog and horse). 
Sensitization at 6, 12 and 24 months was determined using ImmunoCAP (Thermo 
Fisher Scientific, Uppsala, Sweden) for analysis of specific IgE concentrations to egg, 
milk, peanut, cat, dog, birch and timothy. At five years of age, blood samples from the 
children were analysed using Phadiatop for inhalant allergens and fx5, a mix for egg, 
milk, peanut, soy, wheat and cod. If Phadiatop and/or fx5 were positive, specific IgE 
for Phadiatop/fx5 allergens in that sample were analysed. Subjects with allergen 
specific IgE levels ≥0.35 kU/L were regarded as being sensitized. 
 
 
5.4 STATISTICAL ANALYSES 
 
5.4.1 Study I 
The trace element concentrations were not normally distributed and therefore non-
parametric statistical analyses were applied. To compare metal concentrations between 
two independent groups we used Mann-Whitney U-test. To evaluate the correlations 
between trace element concentrations we used Spearman’s rank correlation test. To 
study the influence of lifestyle, gestational age in placenta and cord blood, gestational 
age at blood sampling, maternal age at delivery, parity, herbal medicine intake and 
occupation on the trace element concentrations we used analysis of covariance 
(ANCOVA). To achieve normal distribution of the residuals of the ANCOVAs the 
metal concentrations were log transformed in all cases except for placenta Pb and cord 
blood Co where we used 1/ √metal concentration and for Co in maternal blood where 
we used √Co. For Cd in placenta we used non-transformed concentrations. The 
transformations did not substantially change the results. Statistical analyses were 
performed using SPSS Statistics (IBM SPSS Statistics, version 21, Illinois, USA). 
Significance level was set at 0.05.  
 
 
5.4.2 Study II 
Fatty acids (FAs) were grouped as omega-3 PUFAs, omega-6 PUFAs and ruminant 
FAs and the concentrations were divided in quartiles. The omega-3 PUFAs were 
following; C18:3 n-3 (alpha linolenic acid (ALA)), C18:4 n-3, C20:3 n-3, C20:4 n-3, 
C20:5 n-3 (eicosapentaenoic acid (EPA)), C22:5 n-3 (docosapentaenoic acid (DPA)) 
and C22:6 (docosahexaenoic acid (DHA)). The omega-6 PUFAs were C18:2 n-6 
(linoleic acid (LA)), C18:3 n-6, C20:2 n-6, C20:3 n-6 (dihomo-gammalinolenic acid 
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(DGLA)), C20:4 n-6 (arachidonic acid (AA) and C22:4 n-6. Ruminant FAs were 
C18:1 n-7trans (vaccenic acid (VA)) and C18:2 cis9 trans11 (conjugated linoleic acid 
(CLA)). The exact handling of the FAs in the analyses is described in detail in article II. 
Parental and child sensitization was defined as having specific IgE concentration ≥0.35 
kU/L for at least one allergen. To be defined as non-sensitized, IgE for all seven 
allergens had to be <0.35 kU/L. 
 
Variables considered to be traditional risk factors or influencing sensitization outcome 
were included in the statistical model. The final model was adjusted for the following 
variables; lifestyle, maternal smoking during pregnancy, living on a farm with animals 
during pregnancy, sex, presence of siblings or other children in the household at birth, 
exclusive breastfeeding at two months, parental education and parental sensitization. 
Maternal dietary factors were not included in the model as they might directly influence 
the FA composition. Distribution of demographic variables and potential confounders 
across the lifestyle groups were evaluated using chi-2 test.  
 
The associations between FA concentration in breast milk (exposure) and sensitization 
up to two years of age (outcome) were assessed longitudinally using generalized 
estimating equations (GEE) with a log-link and a poisson distribution168. All analyses 
were performed using R v 3.1.3 (R Foundation for Statistical Computing, Vienna, 
Austria). Significance level was set at 0.05. 
 
 
5.4.3 Study III 
Children with allergen specific IgE concentration ≥ 0.35 kU/L were regarded as 
sensitized. The allergens were grouped into three categories; food (hen’s egg, cow’s 
milk and/or peanut), animal (cat and/or dog) and pollen (birch and/or timothy). Seven 
allergens were analysed at six months, one and two years of age and for longitudinal 
comparison we decided to restrict allergens to those seven also at five years. 
 
Incidences and prevalences for the three allergens were calculated for all four time-
points. Prevalence was calculated as the number of sensitized children by the number of 
non-missing children at each time-point. Incidence proportions were calculated as the 
number of first time sensitized children (cases) during a time-period divided by the 
number of children at risk. Children with previous missing samples were considered at 
risk for the time-period up to the following non-missing sample given that they had not 
been sensitized earlier. 
Chi-square test and analysis of variance (ANOVA) were used for comparison between 
demographic and lifestyle related factors. 
 
We used GEE to investigate if the association between lifestyle and prevalence of 
sensitization for food, animal and pollen sensitization was affected by age of the child. 
Statistical analyses were performed using R v 3.1.3 (R Foundation for Statistical 
Computing, Vienna, Austria) and SAS v9.4 (SAS Institute, Cary, NC). The significance 
level was set at 0.05.  
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5.4.4 Study IV 
The allergen specific IgE concentrations were divided into three categories. Children 
with concentrations below the limit of quantification, 0-0.09 kU/L, were regarded as 
non-sensitized. Levels between 0.1 and 0.34 kU/L were regarded as low levels and 
those ≥ 0.35 kU/L were regarded as sensitized. As described in section “5.3.5 
Sensitization”, the allergens included in the fx5/Phadiatop were analysed only if the 
fx5/Phadiatop was positive. In study IV we replaced the missing negative values at five 
years with the fx5/Phadiatop result divided by the number of allergens included in the 
test (six in fx5/nine in Phadiatop). To evaluate the change in mean egg or milk 
concentrations from six months to five years we used non-parametric Wilcoxon signed 
rank test since the concentrations were not normally distributed. Statistical analyses 
were performed using SPSS Statistics (IBM SPSS Statistics version 23, Illinois, USA). 
The significance level was set at 0.05. 
 
 
5.5 ETHICAL CONSIDERATIONS 
All studies require ethical considerations irrespective of the health status of the 
subjects. The benefits from a study must be greater than its possible adverse effects and 
downsides. Although some participants have found filling out questionnaires to be time 
consuming and some sample collection to be somewhat awkward, most examinations 
and sample collections were non-invasive. The blood sample collection and skin prick-
tests were performed by an experienced paediatric nurse. Emla-adhesive plaster with 
local anaesthetic was used prior to blood sampling to minimize discomfort. 
 
Extensive amounts of questionnaire data and biological samples have been collected. 
The data is stored in encrypted databases separated from personal identity information. 
Social security numbers can only be accessed by the cohort steering group. 
In the ALADDIN cohort, the parents were given oral and written information about the 
study and written consent from both parents was required for participation. 
The study was approved by the local research ethics committee at the Huddinge 
University hospital and the Regional Ethical Review Board, Karolinska Institutet, both 
in Stockholm, Sweden. 
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6 RESULTS AND DISCUSSION 
Demographic characteristics of the subpopulations in study I, II and IV can be found in 
the articles. In general terms, reporting a vegetarian diet, preference of organic 
cultivation, home delivery and delayed washing of infants after birth was more 
common in the anthroposophic group. The distribution of families living on a farm with 
animals and maternal age at delivery was similar in the studied lifestyle groups. 
 
 
6.1 ASSOCIATIONS BETWEEN TRACE ELEMENT CONCENTRATIONS 
AND LIFESTYLE, ARTICLE I 
The concentrations of trace elements in maternal blood, placenta and cord blood are 
presented in Tables 2a, b and c in article I. In contrast to our hypothesis, we found that 
the concentrations of the toxic elements Cd and Pb and the essential element Co were 
higher in the anthroposophic group. 
 
 
Cadmium 
The Cd concentrations in maternal blood and placenta were higher in the 
anthroposophic group compared to the non-anthroposophic group (p<0.001). The 
median Cd concentrations in cord blood were low in both lifestyle groups. 
 
When we studied how the elements correlated within or between tissues we could see a 
linear association between Cd in maternal blood and in placenta (rs=0.36, p=0.001). Cd 
accumulates in the placenta and in our study we found that the Cd concentrations in the 
placentas were on average 12 times higher. 
 
Factors influencing metal concentrations were evaluated using ANCOVA. Results are 
presented in Table 1. 
We could see that only lifestyle was significantly associated with maternal blood Cd 
concentrations (p=0.010). In placenta both lifestyle (p=0.011) and working with art 
(p=0.029) was significantly associated with the Cd concentrations. 
 
Parity, maternal age at delivery, diet or consumption of herbal medicine could not 
explain the measured Cd concentrations in this study. It is known that a preference of 
vegetarian diet as well as a high intake of fibres are associated with higher Cd 
concentrations169,170. Vegetarian diet was not significantly associated with Cd 
concentrations in our study. 45% of the anthroposophic mothers were vegetarians and 
in this sub-population, the vegetarians (0.48µg/kg) and omnivores (0.40 µg/kg) had 
similar Cd concentrations. We speculated that the anthroposophic families might have a 
higher intake of plant-derived food regardless of other dietary preferences. 
 
Unfortunately, we did not have information on maternal blood iron status so it remains 
unclear whether the vegetarian mothers had lower iron status or if iron status alone 
could explain part of the difference in Cd concentrations. 
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Divalent metals are taken up from the intestine by the divalent metal transporter 1 
(DMT1)171. DMT1 is the main iron transporter but it is not specific for iron and 
therefore also transports toxic metals like Cd (and Pb)171. DMT1expression is up 
regulated during pregnancy and in iron deficiency/low iron stores. The transport of 
metals (toxic and essential) is mainly dependent on their availability in diet172,173. 
 
 
Lead 
The concentrations of Pb were higher in the maternal blood (p=0.005) and cord blood 
(p=0.004) in the anthroposophic group. 
Pb passes through the placenta and therefore we found no differences in placental Pb 
concentrations between the lifestyle groups. As expected, maternal and cord blood Pb 
concentrations were highly correlated rs=0.55, p<0.001).  
 
We did not find any explanation for the higher levels of Pb in the anthroposophic 
group. A low calcium diet might influence the gastrointestinal absorption of Pb174,175 
but as the diet in the Nordic countries is rich in calcium sources and since the calcium 
levels were similar in the two lifestyle groups, we do not believe that the calcium 
metabolism could explain the differences seen in Pb. 
 
Working with art and craft is a common and important feature of the anthroposophic 
lifestyle. Mothers could have been exposed to Pb in old paint, working with metals or 
welding. However, working with art could not explain the higher Pb concentrations. 
 
 
Cobalt 
The concentrations of Co were significantly higher in all studied tissues in the 
anthroposophic group compared to the non-anthroposophic group. 
 
Co followed a slightly different pattern with high correlation between maternal blood 
and placenta (rs=0.47, p<0.001) where concentrations in placenta were on average 40 
times those in maternal blood. Also, maternal blood concentrations correlated well with 
those in cord blood (rs=0.35, p=0.003) where the concentrations were quite similar.  
 
Our results showing positive correlations between Cd and Co both in maternal blood 
and placenta indicate that these metals share similar uptake and transport routes as 
shown in previous reports 176-178. 
 
A higher intake of vegetables might also explain the higher Co concentrations seen in 
the anthroposophic mothers as green leafy vegetables, legumes, seeds, nuts and cereals 
are some of the main sources of Co179,180. 
 
Despite the higher levels of toxic Pb and Cd seen in the anthroposophic group, all of 
the measured trace element concentrations in our study are similar to concentrations 
reported by other Nordic studies181,182. 
 
In this study, we did not relate the result to allergic sensitization. It is possible that 
exposure to toxic metals could interfere with prenatal immune development. Cd in 
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placental syncytiotrophoblast cells has been found to suppress transcription of the 
cortisol converting enzyme 11β-hydroxysteroid dehydrogenase type 250,183. We have 
previously shown that children with low salivary cortisol have a lower prevalence of 
allergic sensitization in the first two years of life153. Evaluating this theory in our 
material was however not possible due to time differences in collection and sample 
preparation of the placentas.  
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Table 1 Analysis of covariance for factors influencing cadmium, cobalt and lead concentrations in maternal blood erythrocytes, placenta and cord blood erythrocytes. 
        Maternal blood     Placenta     Cord blood   
  Variable Type Effect size 95% Conf. Int. p-value Effect size 95% Conf. Int. p-value Effect size 95% Conf. Int. p-value 
Cd Lifestyle (anthroposophic) Cat. 0.148 (0.036-0.259) 0.010 1.385 (0.323-2.447) 0.011 0.042 (-0.06-0.145) 0.412 
  Diet (omnivore) Cat. -0.047 (-0.165-0.071) 0.426 -0.662 (-1.737-0.414) 0.224 0.035 (-0.070-0.140) 0.508 
  Herbal medicine (not taken) Cat. 0.056 (-0.053-0.166) 0.308 0.231 (-0.755-1.217) 0.642 -0.005 (-0.099-0.089) 0.917 
  Parity   (one child) Cat. -0.031 (-0.151-0.089) 0.607 -0.201 (-1.287-0.885) 0.713 -0.024 (-0.127-0.080) 0.648 
                 (two children) " -0.075 (-0.174-0.024) 0.137 -0.221 (-1.115-0.674) 0.624 -0.056 (-0.142-0.030) 0.197 
  Occupation (art) Cat. 0.112 (-0.008-0.0233) 0.067 1.25 (0.132-2.367) 0.029 0.104 (-0.007-0.214) 0.066 
  Gestational age* Cont. 0.002 (0.000-0.004) 0.121 0.007 (-0.078-0.093) 0.868 0.000 (-0.007-0.008) 0.918 
  Maternal age  Cont. -0.001 (-0.010-0.008) 0.851 -0.022 (-0.069-0.024) 0.339 0.000 (-0.005-0.004) 0.958 
  Intercept   -0.849 (-1.489-(-0.209)) 0.010 10.114 (-2.598-22.825) 0.117 -1.586 (-2.846-(-0.326)) 0.015 
  
 
  
  
  
  
  
   Co Lifestyle (anthroposophic) Cat. 0.036 (-0.02-0.092) 0.205 0.156 (0.048-0.264) 0.005 -0.301 (-0.734-0.0123) 0.169 
  Diet (omnivore) Cat. -0.059 (-0.118-0.000) 0.051 -0.016 (-0.126-0.094) 0.774 -0.133 (-0.577-0.311) 0.551 
  Herbal medicine (not taken) Cat. -0.001 (-0.056-0.054) 0.982 -0.002 (-0.103-0.098) 0.962 0.255 (-0.142-0.652) 0.204 
  Parity   (one child) Cat. -0.032 (-0.093-0.028) 0.286 -0.019 (-0.130-0.092) 0.734 -0.063 (-0.502-0.375) 0.774 
                 (two children) " 0.022 (-0.027-0.072) 0.373 -0.011 (-0.102-0.080) 0.814 0.054 (-0.310-0.418) 0.768 
  Occupation (art) Cat. 0.007 (-0.054-0.068) 0.82 -0.025 (-0.139-0.089) 0.665 0.297 (-0.170-0.765) 0.208 
  Gestational age* Cont. 0.001 (0.000-0.003) 0.018 -0.01 (-0.018-(-0.001)) 0.033 0.047 (0.014-0.080) 0.007 
  Maternal age  Cont. -0.003 (-0.007-0.002) 0.272 0.004 (0.000-0.009) 0.070 -0.012 (-0.031-0.008) 0.242 
  Intercept   0.078 (-0.243-0.399) 0.630 -0.514 (-1.811-0.784) 0.432 5.478 (0.152-10.803) 0.044 
  
 
  
  
  
  
  
   Pb Lifestyle (anthroposophic) Cat. 0.105 (-0.005-0.215) 0.060 0.142 (-1.185-1.468) 0.832 0.165 (0.023-0.306) 0.023 
  Diet (omnivore) Cat. 0.085 (-0.032-0.201) 0.151 -0.087 (-0.198-0.024) 0.122 0.09 (-0.055-0.235) 0.219 
  Herbal medicine (not taken) Cat. -0.013 (-0.1210.095) 0.809 -0.075 (-0.188-0.037) 0.185 -0.003 (-0.132-0.127) 0.968 
  Parity   (one child) Cat. 0.103 (-0.015-0.221) 0.086 0.01 (-0.093-0.113) 0.851 -0.028 (-0.171-0.115) 0.697 
                 (two children) " -0.073 (-0.171-0.024) 0.138 -0.089 (-0.202-0.025) 0.123 -0.063 (-0.182-0.056) 0.295 
  Occupation (art) Cat. 0.116 (-0.003-0.235) 0.056 0.018 (-0.075-0.111) 0.702 0.033 (-0.12-0.186) 0.670 
  Gestational age* Cont. 0.001 (-0.001-0.004) 0.249 -0.057 (-0.173-0.060) 0.335 -0.003 (-0.013-0.008) 0.642 
  Maternal age  Cont. 0.004 (-0.005-0.013) 0.344 0.003 (-0.006-0.012) 0.448 0.001 (-0.006-0.007) 0.821 
  Intercept   0.668 (0.038-1.298) 0.038 0.002 (-0.003-0.006) 0.524 0.666 (-1.075-2.406) 0.447 
 
For detailed information on statistics, see statistics section. 
            
 
*Gestational age at blood sampling for maternal blood and gestational age at birth (days) for placenta and cord blood. 
    
 
The significance level was set at 0.05 
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6.2 BREAST MILK FATTY ACID COMPOSITION IN RELATION TO 
SENSITIZATION, ARTICLE II 
The 225 mother-child pairs included in this study did not differ from those not included 
regarding lifestyle group and sensitization outcome up to two years of age. Since a 
breast milk sample was required for inclusion, breastfeeding at two months was more 
common among those included. On the other hand, smoking during pregnancy and 
organic diet during breastfeeding was more common among those not included. 
Background and sensitization data on the included mother-child pairs is presented in 
Table 1 in the article. 
 
We found higher concentrations of omega-6 PUFAs compared to omega-3 and 
ruminant FAs in our study. The concentrations of omega-3 and omega-6 PUFAs were 
positively correlated and both were negatively correlated with concentrations of 
ruminant FAs. The total concentrations of FAs are presented in Table 2 and detailed 
information can be found in the article in Figure 1 and in supplementary Table S1. The 
highest concentrations of omega-3 were found in the partly anthroposophic group.  
 
 
Table 2 Concentrations of grouped omega-6, omega-3 and ruminant FAs in breast milk 
samples in the three lifestyle groups. 
Lifestyle ω-6 ω-3 ruminant p-value* 
  wt%, stdev wt%, stdev wt%, stdev   
Non-anthroposophic 11.38 ± 2.32 2.28 ± 0.63 0.76 ± 0.23 0.796 
Partly anthroposophic 11.55 ± 2.58 2.40 ± 1.04 0.86 ± 0.31 0.037 
Anthroposophic 11.28 ± 2.63 2.06 ± 0.83 0.94 ± 0.28 0.002 
*ANOVA was used to test differences in mean values between the three lifestyle groups. 
The concentrations were log transformed. 
 
The result from the longitudinal analysis of overall effect of breast milk FAs on 
sensitization up to two years is presented in Table 3. We found an inverse association 
between omega-3 PUFAs in breast milk and sensitization (adjusted RR, highest vs. 
lowest quartile 0.49, 95% CI 0.023-1.05, p=0.024). Interestingly, a higher AA/EPA 
ratio was associated with a higher risk of sensitization (adjusted RR upper median vs. 
lowest quartile 2.64, 95% CI 1.15-6.07, p=0.029). There were no other significant 
associations between omega-6 PUFAs, ruminant FAs, single FAs or other ratios to 
sensitization in the child.  
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Table 3 Longitudinal analyses of the relative risks between breast milk FA concentrations and 
sensitisation in the child up to 24 months of age in the ALADDIN birth cohort (N=225). 
  Quartiles of fatty acid concentration 
  1 2 3 4   
  Ref RR (95% CI) 1 RR (95% CI) 1 RR (95% CI) 1 p-value  
Fatty acids 
           Omega-3 PUFA2 1.0 0.89 (0.44-1.80) 0.49 (0.23-1.04) 0.49 (0.23-1.05) 0.024 
Omega-6 PUFA2 1.0 1.39 (0.72-2.67) 0.62 (0.27-1.42) 0.89 (0.41-1.92) 0.315 
Ruminant FA2 1.0 0.89 (0.41-1.95) 1.26 (0.60-2.66) 1.07 (0.50-2.31) 0.676 
      Omega-3 
     C18:3 n-3 (ALA) 1.0 1.14 (0.56-2.30) 0.90 (0.44-1.85) 0.67 (0.29-1.58) 0.254 
C22:5 n-3 (DPA) 1.0 1.10 (0.51-2.37) 1.25 (0.59-2.63) 1.21 (0.56-2.59) 0.574 
C22:6 n-3 (DHA) 1.0 1.00 (0.49-2.05) 0.91 (0.44-1.86) 0.62 (0.26-1.48) 0.249 
LC omega-33 1.0 0.82 (0.41-1.65) 0.72 (0.38-1.36) 0.58 (0.29-1.15) 0.111 
      Omega-6 
     C18:2 n-6 (LA) 1.0 1.44 (0.72-2.87) 0.99 (0.45-2.18) 0.84 (0.38-1.89) 0.428 
C20:3 n-6 (DGLA) 1.0 0.60 (0.29-1.25) 0.87 (0.42-1.82) 0.86 (0.43-1.75) 0.911 
C20:4 n-6 (AA) 1.0 0.89 (0.39-2.05) 0.85 (0.38-1.86) 1.36 (0.65-2.87) 0.397 
LC omega-63 1.0 1.02 (0.43-2.43) 1.40 (0.64-3.06) 1.14 (0.49-2.65) 0.598 
      Omega 6/3 ratio 1.0 0.64 (0.27-1.52) 1.51 (0.78-2.93) 1.42 (0.69-2.91) 0.070 
AA/EPA ratio4 1.0 2.92 (1.24-6.87) 2.64 (1.15-6.07) 0.029 
      Ruminant 
     C18:1 n-7 trans (VA) 1.0 0.82 (0.43-1.59) 0.91 (0.45-1.83) 0.74 (0.33-1.65) 0.523 
C18:2 cis 9 trans 11 
(CLA) 1.0 0.68 (0.33-1.40) 0.69 (0.32-1.48) 1.10 (0.54-2.26) 0.848 
GEE was used to get RRs and CIs and test for linear trend was used to get P values.  
1=lowest quartile, 4=highest quartile. 
1Adjusted for lifestyle, sex, parental sensitisation, maternal smoking during pregnancy, living on a farm with animals 
during pregnancy, older children in the household, exclusive breastfeeding at 2 months and parental education. 
2 The group of omega-3 PUFAs includes C18:3 n-3, C18:4 n-3, C20:3 n-3, C20:4 n-3, C20:5 n-3, C22:5 n-3 and C22:6 n-
3. The group of omega-6 PUFAs includes C18:2 n-6, C18:3 n-6, C20:2 n-6, C20:3 n-6 and C20:4 n-6 and C22:4 n-6. 
Ruminant FAs include C18:1n-7tr and C18:2 cis9 trans11. 
3 Long-chain omega-3 FA includes c20:3 n-3, c20:4 n-3, c20:5 n-3, C22:5 n-3 and C22:6 n-3. Long-chain omega-6 FA 
includes C20:2 n-6, C20:3 n-6 and C20:4 n-6 and C22:4 n-6. 
4 EPA concentrations were below the LOQ=0.05 in 47% of samples. These were set to LOQ/√2=0.0354 for the 
purpose of this analysis. All of these samples were in quartiles 3 and 4 of AA/EPA ratios. These quartiles were 
therefore combined. 
 
It would have been desirable to stratify on lifestyle in the longitudinal analysis but as 
the number of sensitized children in the anthroposophic and partly anthroposophic 
group was low, such analysis was not possible. Instead, the effect of FAs on lifestyle 
was assessed in a separate GEE analysis (results presented in Table 3 in the article). In 
this model we adjusted for traditional risk factors (see statistics section). 
 
As in previous studies158, we found that an anthroposophic lifestyle was associated with 
a lower risk of sensitization up to two years of age also in this sup-population (adjusted 
RR anthro. vs. non-anthro. 0.44, 95% CI 0.21-0.90). When separately including omega-
3, omega-6 and ruminant FAs in the model, the RRs remained almost unchanged which 
shows that the lower prevalence of sensitization in the anthroposophic group was not a 
result of FA differences in breast milk. Results from the longitudinal analyses are 
presented in detail in Table 3 in the article. 
 
The observed effect of omega-3 FAs in breast milk on sensitization in our study is in 
line with previous reports and supports the lipid hypothesis109,115,116.  It is nevertheless 
difficult to draw conclusions on the effect of FAs in breast milk as several studies show 
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conflicting results. Opposing results have been observed in studies on high-risk 
populations. The Dutch PIAMA cohort study on allergic and non-allergic mothers and 
their infants up to four years reported that omega-3 PUFAs in breast milk was inversely 
associated with asthma/atopy up to four years in children to allergic mothers184. They 
also reported that alpha linolenic acid (ALA) was positively associated with 
sensitization in children to non-allergic mothers. Although in a later report, with results 
up to 14 years of age, they found no association between ALA and sensitization185. 
Nevertheless, they confirm their previous findings in the children to allergic mothers 
and indeed see that asthma is less prevalent if the breast milk contained higher 
concentrations of omega-3 PUFAs and likewise there was a positive association 
between omega-6 PUFAs and asthma in the children to non-allergic mothers. 
 
It has been shown that living on a farm with animals, especially with exposure to farm 
milk, has an allergy protective effect72,74. A report from the KOALA cohort showed 
that ruminant FAs in breast milk, in addition to omega-3 FAs, were associated with a 
lower risk of atopic manifestations in infancy115. 
Interestingly, a report by Brick et al from the PASTURE study show that the protective 
effect of farm milk could be explained by its higher content of omega-3 PUFAs129. 
 
The association between ruminant FAs and allergy has not yet been extensively studied 
although vaccenic acid (VA) and rumenic acid (RA) have been studied in other 
diseases such as cardiovascular disease186. One study reported that VA in maternal 
plasma during pregnancy was protecting against atopic eczema in infancy187. However, 
in our study we could not see any association between ruminant FAs (or VA or CLA) 
and sensitization. 
 
Consuming fatty fish or fish oil supplements during lactation (≥1-3 times/month) was 
less common in the anthroposophic group compared to the non- and partly 
anthroposophic. This could explain the slightly lower concentrations of omega-3 
PUFAs in the anthroposophic group (Table 2). 
A Cochrane review by Gunaratne et al from 2015 that studied maternal pre and/or 
postnatal omega-3 supplementation for preventing allergies in childhood could not see 
any clear protective effect120. They found that omega-3 supplementation reduced their 
primary outcome of any allergy in children up to 36 months of age and that there was a 
reduction in sensitization to egg and any sensitization during this same time-period. 
The modest observed effect of omega-3 supplementation suggest that there are other 
factors and sources of omega-3 that might be important for the development of 
sensitization.  
 
It was significantly more common among mothers in the partly anthroposophic and in 
the anthroposophic group to eat organically produced food during lactation. We could 
not attribute the sensitization protective effect of lifestyle to the differences in FA 
content of breast milk and we could not include organic diet in the analysis. It would 
have been interesting to study the FA content in breast milk of mothers consuming 
organic dairy products as a recent meta-analysis report higher concentrations of PUFA, 
omega-3 PUFA and CLA in organic milk188. 
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6.3 ASSOCIATION BETWEEN INCIDENCE OF SENSITIZATION AND 
LIFESTYLE, ARTICLE III 
Demographic data for the 474 included children and their parents are presented in 
Table 4. The table was not included in the original article.  Of these 474 children, 100 
came from families with an anthroposophic, 209 from families with a partly 
anthroposophic and 165 from families with a non-anthroposophic lifestyle. Having 
older siblings and being exclusively breastfed at six months were significantly more 
common in the anthroposophic group. In this group, it was also significantly less 
common to receive milk formula during the first week of life. No significant 
differences between the lifestyle groups were found for parental sensitization, maternal 
education, smoking and living on a farm during pregnancy. 
 
Table 4 Demographic data on the 474 children and their parents included in study III. 
Demographic data  
 
Antroposophic Partly 
antroposophic 
Non- 
antroposophic 
P-value* 
Female sex  49/100 (49%) 107/209 (51%) 87/165 (53%) 0.84 
Parental sensitization†  65/100 (65%) 121/198 (61%) 97/162 (60%) 0.70 
Mothers education    0.10 
     Elementary school 4/99 (4%) 6/207 (3%) 8/163 (5%)  
     Gymnasium 29/99 (29%) 75/207 (36%) 72/163 (44%)  
     University 66/99 (67%) 126/207 (61%) 83/163 (51%) 0.10 
Mother smoking during pregnancy  5/99 (5%) 11/206 (5%) 10/163 (6%) 0.92 
Mother living on a farm during pregnancy 7/97 (7%) 14/204 (7%) 11/160 (7%) 0.99 
Mother's age at delivery (years) 33±5.8 32±5.5 31±4.3 0.06 
Having older siblings 77/99 (78%) 120/204 (59%) 102/161 (63%) <0.01 
Exclusive breastfeeding at 6 mo  40/100 (40%) 69/206 (33%) 20/165 (12%) <0.01 
Milk formula during 1st week 14/97 (14%) 41/207 (20%) 52/163 (32%) <0.01 
*Categorical variables presented with n/N (%) and tested with Chi-2 test; continuous variables 
presented with mean ± standard deviation and tested with ANOVA. 
†Parental sensitization was defined as mother and/or father with an IgE level ≥0.35 kU/L against a mix 
of 11 inhalant allergens (ImmunoCAP Phadiatop®, Thermo Fisher Scientific) 
 
Incidence proportions and prevalences of sensitization are presented in Figure 8. The 
incidence proportions of food sensitization in the anthroposophic group were low 
during the first year of life (1% at 0-6 months and 1% at 6-12 months). During the same 
time-period, the incidence proportions in the non-anthroposophic group were 15% and 
16%. In the anthroposophic group, the incidence proportion increased from one to two 
years of age to 8% and remained stable up to five years (9%). In contrast, incidence 
proportions in the non-anthroposophic children decreased from one to two years of age 
(5%) but increased thereafter to 16% from two to five years. In the partly 
anthroposophic group, the incidence proportions were stable and at around 7% in all 
time-periods. 
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Incidence proportions to animal and pollen allergens were similar for the lifestyle 
groups and sensitization seemed to occur later than food sensitization, as expected. 
 
 
Figure 8 Incidence proportions (a-d) and prevalences (e-h) of sensitization to food, 
animal and pollen allergens in children of families with an anthroposophic (green), 
partly anthroposophic (blue) and non-anthroposophic (red) lifestyle. 
 
We used a GEE model to evaluate if the association between lifestyle and sensitization 
was modified by time (the age of the child). We found that age significantly modified 
the association between lifestyle and food allergen sensitization (p=0.020). The 
anthroposophic and partly anthroposophic groups were compared to the non-
anthroposophic group in the model. 
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The results are presented in Figure 9. The association between anthroposophic lifestyle 
and food allergen sensitization was stronger in the first year of life (odds ratios (ORs); 
0.16 at 6 months, 0.18 at one year, 0.25 at two years and 0.58 at five years of age). The 
associations seen for the partly anthroposophic group were similar for all time-points. 
We have previously shown that an anthroposophic lifestyle is associated with a lower 
prevalence of allergic sensitization149,158. Results from this study suggests that this may, 
to a great extent, be related to food allergen sensitization in infancy which indicates that 
the protective effect of an anthroposophic lifestyle may be greater in early life. 
 
 
Figure 9 Associations between lifestyle and prevalences of food, animal and pollen 
sensitization at 6, 12, 24 and 60 months of age. A = anthroposophic, Partly A = partly 
anthroposophic and Non A = non-anthroposophic. ORs and 95% CIs from a 
generalized estimating equation model. 
 
The pattern of allergic sensitization, starting with sensitization against food allergens 
followed by animal and pollen allergen sensitization, has been described earlier14,26,27. 
Few studies have reported the prevalence of allergen sensitization in the first year of 
life13. A study on Estonian and Swedish infants reported the prevalence of milk and egg 
sensitization at six months of age to be as high as 41% (21/51) and that of milk, egg, cat 
and birch allergen sensitization at one year to be 18% (21/114) and at two years 15% 
(18/117)189. This is in accordance with the prevalences in the non-anthroposophic group 
in our study. 
 
In the Dutch KOALA cohort, 27% (215/786) of the children were sensitized to one or 
more common allergens at the age of two years190, which is similar to the 
corresponding prevalence, 24%, in the non-anthroposophic group. 
 
In the MAS study26, including 216 children born in 1990, the prevalence of any 
sensitization at age one year was 11%. In our study, the prevalence in the non-
anthroposophic group was higher, 27%, which may partly be explained by the use of a 
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higher cut-off level for sensitization (0.70 kUA/L) in the German study. However, a 
general rise in the prevalence of sensitization during the last 15 years cannot be ruled 
out. 
 
Tolerance to cow´s milk and hen´s egg usually develops at four to six years of age35,37. 
This tendency could not be seen in this study. Interestingly, both the prevalence and 
incidence of food allergen sensitization in the non-anthroposophic group increased up 
to five years of age. 
 
Another thing worth noting is that both prevalence and incidence of food sensitization 
at five years was slightly higher in the anthroposophic group compared to the partly 
anthroposophic group. The partly anthroposophic group is indeed larger which gives 
better statistical power. One explanation to the age-related differences could be that 
sensitization develops later in the children of anthroposophic families. 
More questions than answers came out of this study and therefore we decided to further 
study the early development of food sensitization in the fourth study. 
 
 
6.4 THE RELEVANCE OF LOW SPECIFIC IGE LEVELS TO EGG, MILK 
AND PEANUT IN INFANCY, ARTICLE IV 
372 children were included in study IV. Demographic data is presented in Table 1 in 
the manuscript. Children were divided into three categories of IgE concentrations at six 
months and followed prospectively until five years. Sensitization development is 
presented in Figures 1-3 in the article. As expected, the prevalence of sensitization at 
six months was low for all three followed allergens. 
 
 
6.4.1 Development of s-IgE to egg 
At six months, 5% (18/369) of the children had low level s-IgE (0.1-0.34 kU/L) (Figure 
10) to egg and 5% (20/369) were sensitized (≥0.35 kU/L). Diagrams for non-sensitized 
and sensitized children are presented in the manuscript in Figure 1. 
 
Following the children with low level s-IgE to egg at six months (Figure 10), we can 
see that at one year the IgE to egg increases in four children but also decreases in the 
same number of children. Thereafter the number of sensitized children and children 
with low levels in this group decreases. At five years, the IgE to egg have decreased to 
below 0.1 in 11/14 of the children. On the other hand, it seems like early low 
sensitization is associated with an increased risk for sensitization to another allergen at 
five years. Five children had a sensitization to another food allergen and ten to an 
inhalant allergen. 
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Figure 10 Development of low levels of s-IgE during the first five years to egg. 
 
Following the children sensitized at six months, the prognosis is less positive compared 
to those with low levels. Egg sensitization is considered to have a worse prognosis, 
increasing the risk for sensitization to inhalant allergens30,31,36. Although limited to 20 
children, similar patterns can be seen in this population. The children sensitized at six 
months were also to a high extent sensitized later even though the ratio of sensitized 
children decreased. Indeed, a majority of these children had a sensitization to food or 
inhalant allergens at five years of age. 
 
For children with samples at both time-points, we compared the median s-IgE 
concentrations at six months to those at five years and found that there was a significant 
decrease in median s-IgE to egg in the children with low levels at six months 
(p=0.011). In the sensitized group the median s-IgE to egg decreased from 1.2 kU/L to 
0.34 kU/L, however the change was not statistically significant. (Figure 4a and b in the 
manuscript). 
 
 
6.4.2 Development of s-IgE to milk 
At six months, 14% (51/372) of the children had low level s-IgE (0.1-0.34 kU/L) 
(Figure 11) to milk and 5% (20/372) were sensitized. Diagrams for non-sensitized and 
sensitized children are presented in the manuscript in Figure 2. 
 
Similar to the low levels to egg, the number of children with low levels to milk 
decreased over time (Figure 11). Interestingly, the proportion developing sensitization 
in this low level group remained at around 20% from 1-5 years. Furthermore, in 
contrast to egg, 12/41 were sensitized to a food allergen at five years where indeed milk 
was the most common allergen. At five years, 15/41 children had developed 
sensitization to an inhalant allergen. 
 
 
Figure 11 Development of low levels of s-IgE during the first five years to milk. 
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Twenty children were sensitized to milk at six months of age and also here the number 
of sensitized children decreased over time. A recent article by Caubet et al. 
investigating tolerance development to milk pointed to an importance of the diversity of 
IgE and IgG4 antibodies to milk protein binding sites191. 
 
In the children sensitized at six months, 9/15 had a sensitization to food (mainly milk) 
and 4/15 were sensitized to an inhalant allergen at five years. 
The decrease in median s-IgE to milk from six months to five years in the children 
sensitized at six months was significant (p=0.004). (Figure 5a and b in the manuscript). 
 
 
6.4.3 Development of s-IgE to peanut 
At six months, 4% (15/367) of the children had low level s-IgE (0.1-0.34 kU/L) (Figure 
12) to peanut and 1% (4/367) were sensitized. Diagrams for non-sensitized and 
sensitized children are presented in the manuscript in Figure 3. 
In the non-sensitized group of children at six months, the number of sensitized children 
increased over time as expected. The majority of those children were multisensitized. 
 
As for egg and milk, there was a trend towards a decrease in s-IgE in the low level 
group. Although, comparing median concentrations between six months and five years 
showed no statistically significant difference (p=0.062). (Figure 6a the manuscript). 
A majority of the children in the low level category were sensitized to a food and/or an 
inhalant allergen at five years (Figure 12). 
 
 
Figure 12 Development of low levels of s-IgE during the first five years to peanut. 
 
In this study, only four children were sensitized to peanut at six months of age. In these 
children, the s-IgE levels increased during the five-year period. Despite the low number 
of peanut sensitized children at six months, the six months and five years median 
values were compared, showing no significant differences (p=0.465). (Figure 6b the 
manuscript). 
 
Low levels of s-IgE has previously been investigated in another Swedish study192. 
Authors for that study categorized low levels as 0.1-0.7 kU/L, thus not entirely 
comparable with our study. Nevertheless, their results were similar showing an 
increased risk of sensitization at five years in the children with levels between 0.1 and 
0.7 kU/L at six months of age. 
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Reactions to food is the most common form of allergy in infancy where egg and milk 
are the most common allergens. Egg sensitization is considered more persistent and 
associated with a worse prognosis compared to milk sensitization26,193. 
This study shows that following s-IgE concentrations, although low, in selected patient 
groups over time can be helpful guiding the physician. It can be discussed what the 
most appropriate cut-off level should be as 0.35 kU/L has little clinical relevance194. 
Stratification on lifestyle was not possible due to the limited number of sensitized 
children. 
 
 
6.5 METHODOLOGICAL CONSIDERATIONS 
The ALADDIN study has a prospective cohort design. 
Before studies are initiated, a “statistical power” calculation is made to estimate the 
number of participants needed in the study which depends on the occurrence of the 
outcome in the population. The confidence intervals reflect precision of the studied 
association. In all studies, we have set the significance level at 0.05 which is standard. 
This means if we would do 100 analyses, 5 of the found associations would be due to 
chance. 
 
There are, however, certain types of errors that may occur in epidemiological studies. 
Selection bias, misclassification bias and confounding in relation to my thesis will be 
addressed in the following section. 
 
 
Selection bias 
Selection bias means there is an unequal distribution of the exposure or outcome 
variables in the participants compared to the non-participants. An example would be 
that parental allergy would affect the decision to participate in a cohort study in only 
one of the studied (exposure) groups. In cohort studies, the risk of selection bias based 
on the outcome is small since the outcome has not occurred at inclusion. 
 
Selection bias can occur at each follow-up as all longitudinal studies have some degree 
of drop-out. The participation rate based on blood sampling and distribution of 
background variables among the participants and non-participants are presented in 
Table 5. 
 
In some cases, parents did not consent to blood sampling in the early age. Adding to 
that, some of the (blood sample) volumes were insufficient to analyse all allergens. In 
those cases, the most prevalent allergens, milk and egg, were prioritized. 
There is a significantly lower number of blood samples at the first three sampling 
occasions from children of anthroposophic parents, a tendency also seen in the 
PARSIFAL study150. However, comparing those parents who did and did not consent to 
blood sampling showed no difference in parental sensitization, family history of atopic 
disease or reported allergies in the parents. Therefore, we do not believe participation in 
blood sampling would introduce selection bias. In addition, consent to blood sampling 
was made before the parents received any results regarding their own or their child’s 
blood sample analyses.  
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Table 5 Distribution of baseline characteristics among the children and their parents at 6 
months, 1, 2 and 5 years. 
    6 months 1 year 2 years 5 years 
    n/N % n/N % n/N % n/N % 
Blood sample analyzed 370/552 67 377/552 68 399/552 72 336/552 61 
Lifestyle     
  
    
  
 
Anthroposophic 71/120* 60 71/120* 60 86/120* 72 74/120 62 
 
Partly anthro. 160/229 70 167/229 73 166/229 73 150/229 66 
 
Non-anthro. 139/170 81 139/170 81 147/170 86 112/170 66 
 
No lifestyle data 0/32 0 0/32 0 0/32 0 0/32 0 
Mother sensitized 108/370 30 116/377 31 113/399 28 104/336 31 
Father sensitized 163/359 45 170/368 46 176/387 46 149/325 46 
Mother university 
educated 185/367 50 188/372 51 195/395 49 166/332 50 
Mother smoking during 
pregnancy 19/366 5 19/371 5 22/395 6 15/332 5 
Having older siblings 237/364 65 230/367 63 254/390 65 215/329 65 
Gender (female) 186/370 50 192/377 51 202/399 51 178/336 49 
Child received antibiotics 
<2mo 15/362 4 16/368 4 14/387 4 11/326 3 
Child received antipyretics 
<2mo 18/361 5 22/366 6 18/386 5 16/325 5 
Breastfeeding 6m     
  
    
  
 
Fully 96/369 26 96/376 26 104/396 26 102/333 31 
  Partly 211/369 57 217/376 58 229/396 58 183/333 55 
*Significant at the 0.05 level. 
   Chi-2 test was used to compare distribution.    
 
 
Selection bias could also be introduced by inclusion criteria for the studies. In all 
studies, we have compared the non-participants to the participants regarding 
background and exposure variables, and found no significant differences concerning 
parental sensitization or later sensitization in the children between those two groups. In 
study I, we randomized the selection of mother-child pairs to minimize selection bias.  
In study II we repeated the longitudinal analysis of the association between FAs in 
breast milk and sensitization up to two years in children with blood samples at all time-
points and found that it did not substantially change our results. Similarly, in study III 
we repeated the analyses with a very strict inclusion criteria that required analysed 
blood samples at all four time-points which gave similar results, although broader CIs, 
as the original analyses. 
 
 
Misclassification/information bias 
Information bias means that the information collected about/from the participants is 
incorrect. This can lead to under/overestimating the studied association. In a cohort 
study, the exposure data is collected before the outcome occurs. The primary exposure 
in the ALADDIN study is lifestyle. In the cross-sectional, pre-ALADDIN study on 
atopy in anthroposophic school children, Alm et al. defined the degree of 
anthroposophy based on 15 exposure factors characteristic of an anthroposophic 
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lifestyle. At the planning of the ALADDIN cohort, the categorization of lifestyle was 
changed to minimize misclassification bias. Instead of researchers choosing lifestyle 
characteristics, the parents were asked about their lifestyle. Then, in the questionnaire 
answers, researchers could search for important exposure variables. 
 
Most of our variables are based on questionnaire answers. It is always a balance 
between asking too detailed questions/taking too much time to answer, and still getting 
information accurate enough to be able to create reasonably good variables, a best 
estimate of reality. 
 
Sensitization was the main outcome variable in articles II-IV. IgE in a serum sample is 
an objective measure with little or no degree of misclassification. IgE levels could serve 
as a marker for allergy that is not dependent on parents’ or doctor’s views on allergic 
disease, especially at young ages when clinical symptoms are sometimes difficult to 
interpret. 
What is relevant though is the interpretation of the IgE value. A good question is what 
is the best, and most clinically relevant cut-off for sensitization? 
 
In study I, the trace element concentrations were measured with ICP-MS in red blood 
cells and placenta. Like the IgE measurement, also mass spectrometry is an objective 
quantification method. The metal concentrations were used as quantitative variables 
and thus, no classification was made. The samples were analysed blinded and in a 
randomized order. It is standard to use quality control samples and blanks in the 
analysis. 
 
It is also relevant to consider if the analysed sample was representative of the true metal 
concentration in the tissue. Although the placenta samples were washed several times 
to drain blood residue, it is possible that the sample contained clotted blood which 
could influence the results. The number of placenta samples available was limited in 
our study, which could make it more difficult to find true associations. 
 
In study II the exposure variable was fatty acids in breast milk samples measured with 
gas chromatography with a flame ionisation detector. The samples were analysed in a 
randomized order. 
We do not have information on the exact time of breast milk sample collection, if it was 
taken before or after meal intake, what the mothers ate that day etc. Detailed 
information would have given the opportunity to exclude that diurnal variation would 
have affected the composition. There are several studies on variation in milk FAs. The 
fatty acid composition does not show diurnal variation although the amount of milk fat 
varies over the course of the day195. The proportions of omega-3 and omega-6 fatty 
acids remain constant over time in mature milk196. It has also been shown that the milk 
FA composition does not change during a feeding197. In our study, we conducted a 
small pilot to see if foremilk or hindmilk would differ in FA concentration. We found 
that it did not affect the FA composition. A variation in FA composition could 
introduce bias in the association between FA composition and sensitization if the 
variation would be systematic. However, we do not believe such systematic variation 
exists. 
 
   43 
 
Confounding 
A confounder is a risk factor for the outcome that is also associated with the exposure 
but not an effect of the exposure. Confounding is always a possible problem in 
epidemiological studies. Known confounders can be included in the analyses or can be 
used for stratification. The problem occurs when the confounder(s) is/are unknown. 
The result of an analysis where confounders have been taken into account/adjusted for, 
is the true effect of the exposure and/or the effect of the exposure plus the effect of an 
unknown confounder. In the ALADDIN study, the main exposure variable is lifestyle. 
If separate lifestyle factors are included in a model and they are true confounders, it 
means they explain the “anthroposophic effect”. The “anthroposophic effect” might be 
a combination of lifestyle factor effects, present in the anthroposophic lifestyle, that 
cannot be separated. A specific problem can arise if a variable is strongly correlated 
with lifestyle. In study I, we decided not to include organic/biodynamic diet in the 
analysis since it was too correlated with anthroposophic lifestyle. 
Figure 13 shows the exposure and outcome variables for each study and the 
variables/confounders included in the analyses. However, unknown confounders can 
still be present. 
 
 
 
 
 
 
Figure 13 Exposure and outcome variables for studies I-IV and the 
variables/confounders included in the analyses. 
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6.5.1 Generalizability 
Importantly, the populations included in the studies in this thesis did not differ from the 
total ALADDIN cohort regarding the main exposure variable, lifestyle, and the main 
outcome variable, sensitization, and thus the results of the studies are generalizable for 
the ALADDIN cohort. Additionally, the populations did not differ regarding parental 
sensitization. 
 
Caution should always be taken when generalizing to a larger population. Compared to 
other epidemiological studies, the ALADDIN study is on the smaller side. The non-
anthroposophic population (n=171) should be representative of the general population. 
Results can be strengthened by comparing to other studies showing similar results or by 
pooling results from similar studies. 
 
Concerning the anthroposophic population studied and its’ representativeness of other 
anthroposophic populations, we can compare our study to the previous cross-sectional 
studies149,150. There seem to be some differences between the Swedish anthroposophic 
population compared to other European anthroposophic populations which shows as 
differences in the protective effect associated with the anthroposophic lifestyle. 
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7 CONCLUSIONS 
 
Based on the research and the articles included in this thesis, the following conclusions 
can be drawn. 
 
 We found higher concentrations of cadmium, cobalt and lead in maternal blood 
and placenta samples from women with an anthroposophic lifestyle and in cord 
blood samples from their infants. None of the factors studied explained the 
lifestyle related differences in metal concentrations but one possible explanation 
could be a diet rich in plant-derived foods. 
 
 We found an inverse association between omega-3 fatty acids in breast milk 
and sensitization in the child up to two years of age. This is in line with 
previous published results of many studies suggesting omega-3 PUFAs might 
protect the child from allergic disease in childhood. However, in our study this 
association did not explain the low prevalence of sensitization among children 
of families with an anthroposophic lifestyle. 
 
 The lower prevalence of allergic sensitization seen among the anthroposophic 
children could be explained by the lower incidence of food allergen 
sensitization in the infancy in this group. It is possible that the allergy protective 
effect of the anthroposophic lifestyle is strongest in the early life. 
 
 Early low levels of s-IgE to milk and egg seem to decrease over time although 
possibly increasing the probability of sensitization to inhalant allergens. Low 
levels to egg seem to be more transient than low levels to milk. 
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8 FUTURE PERSPECTIVES 
 
The results from my thesis adds to previous knowledge about the development of 
allergic sensitization as well as about the characteristics of an anthroposophic 
population. No strong conclusions can be drawn from just single studies and therefore, 
the added knowledge is of great importance for public health work. 
 
A general conclusion from my thesis, and likewise a conclusion in several other allergy 
cohorts, is that the prenatal time and infancy are important time windows for immune 
system development and maturation. The changes and differences seen early often 
persist as seen in prospective settings. Therefore, I believe detailed research in this 
time-frame is of importance for future allergy research. 
 
An area receiving much attention today is food and diet. A majority of the risk factors 
for allergic disease are related to food and diet. I believe research has a great 
responsibility to provide correct and objective information about what is known in the 
field. Information is easily available over the Internet and therefore, it is important that 
authorities are consistent in their recommendations. 
 
Methods today offer possibilities we could not dream of when ALADDIN started in 
2004. Now it is possible to study single cells in detail, conduct metabolomic, 
epigenomic and genome wide analyses. Some of these methods can be applied to the 
existing material, broadening our knowledge about sensitization development in our 
cohort even more. 
 
I would like to end with a section from Susan Prescott’s article on developmental origin 
of allergic disease45. 
 
“..holistic approaches are more likely to simultaneously modify a variety of innate 
immune responses – analogous to the multiple environmental changes currently acting 
simultaneously on many organ systems to exert chronic inflammatory changes”. 
 
The anthroposophic lifestyle might be just that.   
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9 SVENSK SAMMANFATTNING 
 
Allergisjukdomar har stadigt ökat under det senaste seklet för att nu utgöra en del av 
vår tids folksjukdomar. Allergier drabbar nu nästan vartannat barn i västvärlden och 
debuterar ofta som födoämnesallergi, speciellt mot mjölk och ägg. 
 
Grunden i sjukdomen är ett avvikande beteende hos immunsystemet där kroppens 
immunceller börjat försvara sig mot ofarliga ämnen (allergener) i vår omgivning. Om 
så kallade IgE antikroppar produceras mot allergenet, benämns det allergisk 
sensibilisering. 
 
Orsaken till allergiökningen är fortfarande till stor del okänd. Ärftlighet är en viktig 
faktor men kan inte förklara den snabba ökningen. Orsaken tros vara förändringar i 
livsstil, som i kombination med omgivningsfaktorer påverkar vårt immunsystem. Till 
sådana faktorer kan räknas mikrober, infektioner, förlossningssätt, amning, stress, 
rökning, miljöföroreningar och kemikalier i vår hemmiljö. Studier har visat att barn 
uppväxta på bondgårdar med nära kontakt till djur och som dricker opastöriserad 
komjölk har en lägre förekomst av allergier. 
 
Vi har tidigare visat att barn i familjer med en antroposofisk livsföring har en låg 
förekomst av allergier. Den antroposofiska livsstilen innefattar flera hypotetiskt 
intressanta aspekter, bl.a. väljer de flesta att äta ekologiskt eller biodynamiskt 
producerad mat och mjölksyrade grönsaker innehållande levande bakteriekultur. 
Barnen föds ofta hemma och den antroposofiska sjukvården har en restriktiv syn på 
användningen av vaccinationer, antibiotika och febernedsättande läkemedel. I stället 
används ofta homeopatiska naturläkemedel. 
 
Mitt avhandlingsarbete utgår från den prospektiva födelsekohorten ALADDIN 
(Assessment of Lifestyle and Allergic Disease During INfancy) där vi undersöker 
och försöker identifiera livsstils- och omgivningsfaktorer som påverkar 
allergiutvecklingen. 
 
I arbete I undersökte vi om mammor med en antroposofisk livsstil har en lägre 
exponering för potentiellt immunstörande toxiska metaller. Vi mätte koncentrationerna 
av tre toxiska och nio essentiella metaller i blod från mamman, i placenta och i 
navelsträngsblod hos 40 mamma-barnpar med och 40 utan en antroposofisk livsstil. Vi 
fann högre nivåer av kadmium, bly och kobolt i mamma-barnpar med en antroposofisk 
livsstil. Orsaken till denna skillnad kunde inte förklaras med någon av de specifika 
livsstilsfaktorer vi registrerat. Trots de högre nivåerna var ändå alla 
metallkoncentrationer inom nivåer som anses normala. 
 
I arbete II undersökte vi om den lägre förekomsten av allergisk sensibilisering hos 
barn i antroposofiska familjer kunde bero på en skillnad i bröstmjölkens 
fettsyresammansättning. Vi mätte koncentrationerna av långkedjade fleromättade 
fettsyror i bröstmjölksprover från 225 mammor och undersökte förekomsten av 
allergisk sensibilisering fram till två års ålder hos barnet. Vi såg att högre halter av 
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omega-3-fettsyror i bröstmjölken var kopplat till en lägre risk för allergisk 
sensibilisering. Detta förhållande kunde dock inte förklara den lägre förekomsten av 
sensibilisering hos barn i antroposofiska familjer. 
 
I arbete III undersökte vi om incidensen (insjuknandet) och prevalensen 
(förekomsten) av födoämnes-, djur- och pollensensibilisering fram till fem års ålder 
påverkades av barnets ålder. Vi undersökte 100 antroposofiska, 209 delvis 
antroposofiska och 165 icke-antroposofiska barn. Vi fann en lägre incidens av 
födoämnessensibilisering hos barn tillhörande antroposofiska familjer. Vi kunde 
därmed förklara att den lägre förekomsten av allergisk sensibilisering hos barn från 
antroposofiska familjer nästan uteslutande beror på en lägre risk för 
födoämnessensibilisering före ett års ålder. 
 
I arbete IV har vi beskrivit förloppet av IgE-sensibilisering mot ägg, mjölk och 
jordnöt fram till fem års ålder hos 372 barn. Vi delade in IgE-koncentrationerna i icke-
sensibiliserade (≤ 0,09 kU/L), låga nivåer (0,1-0,34 kU/L) och sensibiliserade (≥ 0,35 
kU/L). Vi kunde se att de barn som hade låga IgE-nivåer av ägg och mjölk vid sex 
månaders ålder blev färre till antalet över tid, men att det samtidigt kunde öka risken 
att senare sensibiliseras mot ett luftburet allergen. Låga nivåer mot ägg visade sig vara 
mer övergående än låga nivåer mot mjölk. 
 
Sammanfattningsvis beskriver denna avhandling, tillsammans med tidigare arbeten 
inom ALADDIN-kohorten, att tidig exponering för livsstil och omgivningsfaktorer har 
stor betydelse för immunsystemets mognad och utveckling av allergisk sjukdom. 
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